WO2023075165A1 - Antimicrobial composition comprising antiseptic compound and reuterin, and use thereof - Google Patents
Antimicrobial composition comprising antiseptic compound and reuterin, and use thereof Download PDFInfo
- Publication number
- WO2023075165A1 WO2023075165A1 PCT/KR2022/014266 KR2022014266W WO2023075165A1 WO 2023075165 A1 WO2023075165 A1 WO 2023075165A1 KR 2022014266 W KR2022014266 W KR 2022014266W WO 2023075165 A1 WO2023075165 A1 WO 2023075165A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- luterin
- weight
- preservative
- cosmetic composition
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 137
- 150000001875 compounds Chemical class 0.000 title claims abstract description 55
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 28
- 230000002421 anti-septic effect Effects 0.000 title claims abstract description 14
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 title abstract description 17
- 239000002537 cosmetic Substances 0.000 claims abstract description 94
- 239000003755 preservative agent Substances 0.000 claims abstract description 77
- 230000002335 preservative effect Effects 0.000 claims abstract description 57
- 239000004599 antimicrobial Substances 0.000 claims abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 85
- 241000894006 Bacteria Species 0.000 claims description 28
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 23
- 241000233866 Fungi Species 0.000 claims description 19
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 18
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 17
- 239000004299 sodium benzoate Substances 0.000 claims description 17
- 235000010234 sodium benzoate Nutrition 0.000 claims description 17
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 15
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 15
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 15
- -1 alkane diol Chemical class 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229960003885 sodium benzoate Drugs 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 238000009472 formulation Methods 0.000 abstract description 29
- 244000005700 microbiome Species 0.000 abstract description 14
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 230000002829 reductive effect Effects 0.000 abstract description 2
- 241000228245 Aspergillus niger Species 0.000 description 19
- 241000222122 Candida albicans Species 0.000 description 17
- 238000011156 evaluation Methods 0.000 description 16
- 239000002609 medium Substances 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 239000006210 lotion Substances 0.000 description 10
- 230000000843 anti-fungal effect Effects 0.000 description 8
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 6
- 229940031723 1,2-octanediol Drugs 0.000 description 6
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 6
- 229940073735 4-hydroxy acetophenone Drugs 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 6
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 6
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 6
- 229940015975 1,2-hexanediol Drugs 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 241000186604 Lactobacillus reuteri Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DCTMXCOHGKSXIZ-UHFFFAOYSA-N (R)-1,3-Octanediol Chemical compound CCCCCC(O)CCO DCTMXCOHGKSXIZ-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000005757 colony formation Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 2
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 2
- XMTUJCWABCYSIV-UHFFFAOYSA-N octane-2,3-diol Chemical compound CCCCCC(O)C(C)O XMTUJCWABCYSIV-UHFFFAOYSA-N 0.000 description 2
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229960000281 trometamol Drugs 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical class OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- 241000480567 Pseudomonas aeruginosa C Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229940075510 carbopol 981 Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 231100000045 chemical toxicity Toxicity 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- GTZOYNFRVVHLDZ-UHFFFAOYSA-N dodecane-1,1-diol Chemical compound CCCCCCCCCCCC(O)O GTZOYNFRVVHLDZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 231100000049 endocrine disruptor Toxicity 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940013688 formic acid Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 description 1
- 229960001915 hexamidine Drugs 0.000 description 1
- AVIYEYCFMVPYST-UHFFFAOYSA-N hexane-1,3-diol Chemical compound CCCC(O)CCO AVIYEYCFMVPYST-UHFFFAOYSA-N 0.000 description 1
- QCIYAEYRVFUFAP-UHFFFAOYSA-N hexane-2,3-diol Chemical compound CCCC(O)C(C)O QCIYAEYRVFUFAP-UHFFFAOYSA-N 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- RUOPINZRYMFPBF-UHFFFAOYSA-N pentane-1,3-diol Chemical compound CCC(O)CCO RUOPINZRYMFPBF-UHFFFAOYSA-N 0.000 description 1
- XLMFDCKSFJWJTP-UHFFFAOYSA-N pentane-2,3-diol Chemical compound CCC(O)C(C)O XLMFDCKSFJWJTP-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to an antibacterial composition, a cosmetic composition, and a preservative for cosmetic preservation containing a preservative compound and luterin for inhibiting the activity of microorganisms or killing microorganisms.
- Microorganisms decompose organic matter or organic compounds to produce substances useful to humans, but also produce substances harmful to humans with odors and chemically and biologically degenerate them.
- contamination by microorganisms during the manufacturing process and microbial contamination by skin contact such as fingers during use cannot be avoided.
- the use of preservatives is unavoidable.
- Preservatives are formulated into cosmetics to suppress the proliferation of microorganisms that contaminate cosmetics from the outside, and to prevent product changes by killing microorganisms over time.
- Preservatives that are mainly used are synthetic preservatives containing chemical substances, such as paraoxybenzoic acid esters (parabens), imidazolidinyl urea, phenoxyethanol, etc., and diols with two hydroxyl groups.
- a based compound or surfactant may also be used as a preservative.
- luterin a natural antibacterial substance, has been reported as a substance showing a wide spectrum of antimicrobial activity.
- the antibacterial activity is low in the presence of amino acids, it is difficult to apply to products containing amino acids (Eunmi Yeom et al., Journal of Korean Food Science 2004. 36(1): 111-115).
- Patent Document 1 Republic of Korea Patent Registration No. 10-2013565
- Patent Document 2 Republic of Korea Patent Registration No. 10-2136623
- Patent Document 3 Republic of Korea Patent Registration No. 10-1472518
- An object of the present invention is to provide an antibacterial composition for inhibiting the activity of microorganisms such as bacteria and fungi or killing microorganisms, a cosmetic composition, and a preservative for cosmetic preservation.
- One aspect of the present invention provides an antimicrobial composition
- an antimicrobial composition comprising an antiseptic compound and luterin as active ingredients.
- preservative compound used in the present invention refers to a compound added to prevent chemical or biological deterioration of a substance, and may include a compound used as a preservative or disinfectant.
- a preservative or disinfectant In view of the chemical toxicity of preservative compounds, cosmetics, foods, and medicines must use safe substances that are not toxic to the human body, so in the present invention, any preservative compound that is chemically safe and harmless can be used without limitation.
- preservative compound examples include parabens, paraffins, alkanediols, phenoxyethanol, imidazolidinyl urea, diazolidinyl urea ), isopropyl alcohol, chlorophene, formic acid, piroctone olamine, hexetidine, hexamidine, isothiazolinone ), hydroxyacetophenone, glyceryl caprylate, ethylhexylglycerin, sodium benzoate, etc., but are not limited thereto.
- the preservative compound may be at least one selected from the group consisting of alkane diol, hydroxyacetophenone, glyceryl caprylate, ethylhexyl glycerin and sodium benzoate.
- the alkane diol refers to a compound in which two hydroxyl groups (-0H) are connected to a saturated hydrocarbon (alkane) that forms a chain with a single bond between carbons. It is classified as 1,4-, 2,3-, 2,4-, 2,5-, etc.
- alkanediols are mainly used as moisturizing ingredients in cosmetics and pharmaceuticals, but since they contain a hydrophilic hydroxyl group and a hydrophobic carbon chain, they are amphiphilic and can easily penetrate cell membranes of microorganisms, thereby exhibiting excellent antibacterial activity.
- the alkanediol preferably has 3 to 12 carbon atoms.
- the alkane diol may be an alkane diol having 3 to 12 carbon atoms.
- the alkanediol includes propanediol, butanediol, pentanediol, hexanediol, octanediol, decanediol and dodecanediol. It may be one or more selected from the group consisting of.
- the alkanediol may be at least one selected from the group consisting of propanediol, butanediol, pentanediol, hexanediol, and octanediol.
- 1,2-alkanediol, 1,3-alkanediol, or 2,3-alkanediol is preferable to enhance antibacterial activity.
- the hydroxyacetophenone is a plant-derived ingredient used as a natural antioxidant in cosmetics, and has a weaker preservative power than parabens, but is more skin-friendly and increases the preservative function when used with other preservatives including parabens.
- These hydroxyacetophenones are classified into 2-, 3- and 4-hydroxyacetophenones according to the position of the hydroxy group (-OH), but there is no difference in preservative function.
- the glyceryl caprylate is a plant-derived ingredient that serves as a kind of surfactant and is mainly used as an emulsifier in cosmetics, and has excellent antibacterial and antifungal effects, so it can be used as a substitute for preservatives.
- the ethylhexylglycerin has a wetting property and is mainly used for the moisturizing effect of cosmetics, but also serves to increase the antibacterial power of common preservatives such as phenoxyethanol, isothiazolinone, and paraben, and is used to reduce the amount of such preservatives. It also has antibacterial activity that inhibits the growth of odor-causing anaerobic bacteria in the human body.
- the sodium benzoate is a compound that is effective in inhibiting the growth of various microorganisms such as bacteria, yeast, and fungi. It is inexpensive, has excellent antibacterial effect, and is low in toxicity, and is mainly used as a food preservative. In cosmetics, it replaces parabens. It is one of the synthetic preservatives.
- reuterin refers to 3-hydroxypropionaldehyde, a natural antimicrobial substance produced by Lactobacillus reuteri from glycerol.
- the luterin has antibacterial activity against not only pathogenic bacteria but also yeast and mold, and thus has a very broad antibacterial spectrum (Doleyres et al., Appl Microbiol Biotechnol 2005, 68: 467-474).
- the luterin may be isolated from Lactobacillus reuteri or a culture medium thereof.
- the "culture medium” used in the present invention refers to nutrients necessary for the survival, development, or proliferation of Lactobacillus reuteri, and may also include enzymes and metabolites produced by the Lactobacillus reuteri and secreted to the outside.
- a composition comprising such an antiseptic compound and luterin may exhibit antibacterial activity.
- Antimicrobial as used in the present invention means the ability to reduce, prevent, inhibit or eliminate the growth or survival of microorganisms such as bacteria and fungi at a certain concentration
- antimicrobial composition refers to substances exhibiting such antibacterial activity. means a composition comprising
- the antimicrobial composition may have antibacterial activity against bacteria and fungi.
- the antibacterial composition is Escherichia (Escherichia ) genus, Staphylococcus ( Staphylococcus ) genus, Pseudomonas ( Pseudomonas ) genus, Candida ( Candida ) and Aspergillus ( Aspergillus ) genus It may have antibacterial activity against one or more bacteria selected from the group consisting of.
- the antibacterial composition contains a preservative compound and luterin, thereby exhibiting sufficient antibacterial activity even in a small amount compared to the amount of preservative compound or luterin used for antibacterial activity in the past, maintaining formulation stability of the product and extending shelf life. can do.
- the antimicrobial composition may be one containing 0.01 to 50% by weight of an antiseptic compound based on the total weight.
- the amount of the preservative compound is 0.01 to 50% by weight, 0.01 to 10% by weight, 0.01 to 5% by weight, 0.01 to 1% by weight, 0.05 to 50% by weight, 0.05 to 50% by weight based on the total weight of the antimicrobial composition.
- to 10 wt% 0.05 to 5 wt%, 0.05 to 1 wt%, 0.1 to 50 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 1 wt%, 0.5 to 50 wt%, 0.5 to 10 0.5 to 5 wt%, 0.5 to 1 wt%, 1 to 50 wt%, 1 to 10 wt%, 1 to 5 wt%, 5 to 50 wt%, or 10 to 50 wt%.
- the amount of the preservative compound When the amount of the preservative compound is less than 0.01% by weight, antibacterial activity against bacteria and fungi is not shown, and a large amount of luterin is unavoidable to improve antibacterial activity, and when the amount of the preservative compound exceeds 50% by weight, the product This thinning may cause a problem with formulation stability and greatly increase skin irritation.
- the antimicrobial composition may contain 0.05 to 50 mM of luterin.
- the concentration of luterin in the antimicrobial composition is 0.05 to 50 mM, 0.05 to 10 mM, 0.05 to 5 mM, 0.1 to 50 mM, 0.1 to 10 mM, 0.1 to 5 mM, 0.5 to 50 mM, 0.5 to 10 mM, 0.5 to 5 mM, 1 to 50 mM, 1 to 10 mM, or 1 to 5 mM.
- concentration of luterin is less than 0.05 mM, it may not exhibit antibacterial activity or may show limited antibacterial activity only in some microorganisms, and if the concentration of luterin exceeds 50 mM, formulation stability may be adversely affected.
- luterin exhibits antibacterial activity against bacteria ( E. Coli , P. aeruginosa and S. aureus ) and fungi ( C. albicans and A. niger ) even when used alone, but is a preservative compound.
- This antibacterial composition can be applied in any formulation such as liquid, oil, cream, paste, solid, etc., and can be used for products applied to the body, such as the body, skin, oral cavity, and hair.
- the antibacterial composition according to the present invention may be utilized in various fields depending on the purpose or aspect of use, and may be embodied as, for example, a cosmetic composition or an additive thereof.
- the additive is an additive for preventing deterioration, decay, discoloration, and chemical change of the product by microorganisms, and may be a preservative, a preservative, a bactericide, etc., based on the total weight of the cosmetic composition, 0.01 to 50% by weight, 0.5 to 25% by weight, 0.1 to 10% by weight, or 0.5 to 5% by weight may be included.
- Antibacterial composition according to the present invention can be implemented as a cosmetic composition.
- the cosmetic composition may contain an antibacterial compound and luterin as active ingredients.
- the cosmetic composition may further include ingredients commonly used in cosmetic compositions, for example, antioxidants, stabilizers, solubilizers, vitamins, pigments, fragrances, and the like.
- the cosmetic composition may be prepared without limitation in formulations commonly used in the art, for example, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrient lotion, massage cream, nutrient cream , Moisture Cream, Hand Cream, Essence, Nutrition Essence, Pack, Soap, shampoo, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body Lotion, Body Cleanser, Emulsion, Lipstick, Makeup Base, Foundation, Press Powder, Loose Powder, Eye Shadow It can be prepared in formulations such as
- the cosmetic composition may include 0.01 to 50% by weight of an antiseptic compound based on the total weight.
- the amount of the preservative compound is 0.01 to 50% by weight, 0.01 to 10% by weight, 0.01 to 5% by weight, 0.01 to 1% by weight, 0.05 to 50% by weight, 0.05 to 50% by weight based on the total weight of the cosmetic composition. 10 wt%, 0.05 to 5 wt%, 0.05 to 1 wt%, 0.1 to 50 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 1 wt%, 0.5 to 50 wt%, 0.5 to 10 wt% %, 0.5 to 5%, 0.5 to 1%, 1 to 50%, 1 to 10%, 1 to 5%, 5 to 50%, or 10 to 50%.
- the cosmetic composition may contain 0.05 to 50 mM of luterin.
- the concentration of luterin in the cosmetic composition is 0.05 to 50 mM, 0.05 to 10 mM, 0.05 to 5 mM, 0.1 to 50 mM, 0.1 to 10 mM, 0.1 to 5 mM, 0.5 to 50 mM, 0.5 to 10 mM, 0.5 to 5 mM, 1 to 50 mM, 1 to 10 mM, or 1 to 5 mM.
- the antibacterial composition according to the present invention can be implemented as a preservative for preserving cosmetics.
- the preservative for preserving cosmetics may be a preservative for preserving cosmetics containing a preservative compound and luterin as active ingredients.
- the preservative for preserving cosmetics is an additive used in manufacturing cosmetics to prevent spoilage, and particularly serves to prevent biological deterioration.
- the preservative for preserving cosmetics may include 0.01 to 50% by weight of a preservative compound based on the total weight.
- the amount of the preservative compound is 0.01 to 50% by weight, 0.01 to 10% by weight, 0.01 to 5% by weight, 0.01 to 1% by weight, 0.05 to 50% by weight, based on the total weight of the preservative for cosmetic preservation.
- the preservative for preserving cosmetics may contain 0.05 to 50 mM of luterin.
- the concentration of luterin is 0.05 to 50 mM, 0.05 to 10 mM, 0.05 to 5 mM, 0.1 to 50 mM, 0.1 to 10 mM, 0.1 to 5 mM, 0.5 to 50 mM, 0.5 to 10 mM in the preservative for cosmetic preservation. , 0.5 to 5 mM, 1 to 50 mM, 1 to 10 mM, or 1 to 5 mM.
- the preservative for preserving cosmetics may further include components commonly used depending on the type and purpose of use of the product, and may further include, for example, acetic acid, sodium acetate-based, sorbic acid-based, benzoic acid-based, propionic acid-based, etc. .
- the antibacterial composition according to the present invention can improve formulation stability by minimizing the amount of preservative compound and luterin by including a preservative compound and luterin, and can secure antimicrobial activity in the formulation even if the amount used is reduced compared to the use of a preservative compound or luterin alone. It can be used as a preservative compound or a cosmetic composition that compensates for the disadvantages of luterin, a preservative for cosmetic preservation, and the like.
- FIG. 1 is a graph showing the change in viscosity of a cosmetic composition including an antibacterial composition according to an embodiment of the present invention.
- Alkanediols of (1,2-HD) and 1,2-octanediol (1,2-OD) 4-hydroxyacetophenone (4-HA), glycerylcaprylate (GC), ethylhexylglycerin (EHG) ) and sodium benzoate (SB) were used.
- Reuterin was obtained and used through microbial culture.
- MRS medium (10 g/L Proteose Peptone NO.3, 10 g/L beef extract, 5 g/L yeast extract, 20 g /L dextrose, 1 g/L polysorbate 80, 2 g/L ammonium citrate, 5 g/L sodium acetate, 0.1 g/L magnesium sulfate, 0.05 g/L manganese sulfate, and After culturing in 2 g/L of dipotassium sulfate), the culture medium was centrifuged at 13,000 rpm for 5 minutes, and the cells were collected and washed twice in 50 mM sodium phosphate buffer (pH 7.5).
- the washed cells were resuspended in a 200 mM glycerol solution, allowed to stand in an incubator at 30° C., and samples were taken at intervals of 1 hour. Reuterin at a concentration of 100 mM was obtained and used in subsequent examples.
- Antibacterial evaluation was performed on the antibacterial composition containing alkanediol and luterin.
- luterin alone or luterin and alkanediol were mixed at a weight ratio of 1: 1 and added to 0.5 to 4% by weight. At this time, in the medium The final luterin concentration was 0.5 to 4 mM. Thereafter, bacteria were inoculated to a concentration of 10 7 cfu/ml and cultured at 37°C for 1 day, or fungi were inoculated to a concentration of 10 5 cfu/ml and cultured at 30°C for 2 days to confirm the MIC value. The results are shown in Table 1 below.
- the antibacterial composition contains 0.1 to 30 wt. weight of alkanediol (1,3-propanediol, 2,3-butanediol, 1,2-pentanediol, 1,2-hexanediol or 1,2-octanediol) in 0.85% NaCl buffer. % and/or 0.1 to 3 wt% (0.1 to 3 mM) of lutein. 10 5 cfu/mL of C. albicans or A. niger was inoculated in 10 mL of the antibacterial composition and cultured with shaking for 72 hours in a 30°C incubator.
- the MBC (minimum bactericidal concentration) evaluation results for C. albicans and A. niger are shown in Tables 2 and 3, respectively.
- Formulation stability was confirmed by preparing a cosmetic composition containing an alkanediol alone or an alkanediol and luterin. 1,2-HD was used as the alkanediol.
- the raw materials and contents of the cosmetic composition are shown in Table 4 below, and were prepared in a lotion formulation.
- Cosmetic Composition 1 Cosmetic Composition 2
- Carbopol 981 0.2wt% 0.2wt% Glycerin 5.0wt% 5.0wt% Cetyl alcohol 0.5wt% 0.5wt% Stearyl alcohol 0.5wt% 0.5wt% MCTs 2.0wt% 2.0wt% LP 70 3.0wt% 3.0wt% Olivem 1000 1.5wt% 1.5wt% Triethanolamine 0.2wt% 0.2wt% 1,2-HD 3.0wt% 1.0wt% Reuterin 0 1.0 wt % (1 mM) Distilled water To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt% To 100wt%
- Viscosity evaluation (unit: cps) was conducted by putting each cosmetic composition in a transparent container and operating a viscometer (LV pro VISCOMETER, BROOKFIELD) equipped with a No. 64 spindle at 25 ° C. at 50 rpm.
- cosmetic composition 1 containing 1,2-HD alone showed a decrease in viscosity
- cosmetic composition 2 containing 1,2-HD and luterin showed no change in viscosity. confirmed that
- An antimicrobial composition containing hydroxyacetophenone, glyceryl caprylate, ethylhexyl glycerin or sodium benzoate, and luterin was subjected to antibacterial evaluation.
- fungi Candida albicans ATCC 10231 and Aspergillus niger ATCC 16404 designated by the United States Pharmacopoeia were used.
- C. albicans was subcultured twice in SDB medium, and A. niger spores obtained by plating on SDA medium were used in the experiment.
- luterin alone or luterin and an antiseptic compound were added at respective concentrations to a 0.8% NaCl aqueous solution, and the final concentration of luterin was 0.5 to 1.5 mM. Thereafter, the fungus was inoculated to 10 5 cfu/ml, stored at 30° C. for 3 days, and then 100 uL was smeared on SDA medium. The smeared samples were incubated at 30° C. for 3 days to confirm whether or not colonies were formed. The results are shown in Table 5 below.
- antifungal activity was observed when 0.1 to 0.2% by weight of hydroxyacetophenone, 0.1 to 0.2% by weight of glyceryl caprylate, 0.05 to 0.1% by weight of ethylhexylglycerin, or 0.3 to 0.4% by weight of sodium benzoate was used alone. However, it was confirmed that antifungal activity appeared as the concentration of luterin increased.
- Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027, and Staphylococcus aureus ATCC 6538 designated by the United States Pharmacopoeia (USP) were used. Bacteria were subcultured twice in TSB medium and used in experiments.
- luterin alone or luterin and an antiseptic compound were added at respective concentrations to a 0.8% NaCl aqueous solution, and the final concentration of luterin was 0.5 to 1.5 mM. Thereafter, the bacteria were inoculated to a concentration of 10 7 cfu/ml, stored at 37° C. for 3 days, and then 100 uL was smeared on a TSA medium. The smeared sample was incubated at 37 ° C. to confirm the presence or absence of colony formation. The results are shown in Table 6 below.
- Each cosmetic composition was inoculated to 10 7 cfu/ml for bacteria and 10 5 cfu/ml for fungi, and then stored at 37°C and 30°C for 3 days, respectively. After mixing 100 uL of the sample with 900 uL of Letheen medium, it was smeared on TSA for bacteria and SDA for fungi, respectively. The smeared samples were incubated at 37 ° C and 30 ° C for 3 days, respectively, to confirm the presence or absence of colony formation. The results are shown in Table 9 below.
- '4-2 In order to check whether the antibacterial activity in the cosmetic formulation is maintained, '4-2. It was confirmed whether the antibacterial activity was maintained by cumulatively inoculating each strain using the bacterial or fungal inoculated samples (cosmetic compositions 4 to 7 and 9 to 12) used in 'Evaluation of antibacterial activity in cosmetic formulations'.
- bacteria three species, namely E. coli , P. aeruginosa and S. aureus were mixed and inoculated to 10 7 CFU/ml, and in the case of fungi, C. albicans and A. niger were mixed to 10 5 CFU/ml, respectively. Inoculated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to an antimicrobial composition, a cosmetic composition, and a preservative for preserving cosmetics, the antimicrobial composition comprising an antiseptic compound and reuterin in order to inhibit microbial activity or kill microorganisms. The antimicrobial composition comprises the antiseptic compound and reuterin and thus may be used as a cosmetic composition, a preservative for preserving cosmetics, etc. whereby the amount of use of the antiseptic compound is minimized, and thus formulation stability may be improved, and the amount of use may be reduced compared to when using reuterin alone, and thus antimicrobial activity in the formulation may be secured, and thus disadvantages of the antiseptic compound or reuterin are compensated for.
Description
본 발명은 미생물의 활성을 저해하거나 미생물 사멸을 위한 방부 화합물 및 루테린을 포함하는 항균용 조성물, 화장료 조성물 및 화장품 보존용 방부제에 관한 것이다.The present invention relates to an antibacterial composition, a cosmetic composition, and a preservative for cosmetic preservation containing a preservative compound and luterin for inhibiting the activity of microorganisms or killing microorganisms.
미생물은 유기물 또는 유기 화합물을 분해하여 사람에게 유용한 물질을 생성하기도 하지만 악취와 함께 사람에게 해로운 물질을 생성하며 화학적, 생물학적으로 변질시킨다. 특히 화장품의 경우, 제조공정 중 미생물에 의한 오염, 사용 중 손가락 등의 피부 접촉에 의한 미생물 오염 등을 피할 수 없기 때문에 통상 미생물의 증식을 억제하고 보존 과정에서 미생물을 사멸시켜 제품의 보존성을 향상시키기 위해서는 방부제의 사용이 불가피하다. Microorganisms decompose organic matter or organic compounds to produce substances useful to humans, but also produce substances harmful to humans with odors and chemically and biologically degenerate them. In particular, in the case of cosmetics, contamination by microorganisms during the manufacturing process and microbial contamination by skin contact such as fingers during use cannot be avoided. The use of preservatives is unavoidable.
방부제는 화장품에 배합되어 외부로부터 화장품을 오염시키는 미생물의 증식을 억제하며, 시간 경과와 함께 미생물을 사멸시켜 제품의 변화를 방지한다. 주로 사용되는 방부제로는 화학 물질을 포함하는 합성 방부제로, 파라옥시안식향산에스테르 (파라벤류), 이미다졸리디닐우레아, 페녹시에탄올 등이 있으며, 2개의 수산기(hydroxyl group)를 가지는 디올(diol)계 화합물이나 계면활성제도 방부제로 사용될 수 있다. 그러나 합성 방부제 중 파라벤류는 알러지 반응 및 환경호르몬으로서의 가능성, 내성균 유발 등의 문제점이 있으며, 디올계 화합물이나 계면활성제는 항진균 활성이 약하고 제품을 묽게 만들어 제형 안정성에 문제가 있고 피부 자극이 크다는 점도 지적되고 있다. 이러한 합성 방부제의 안정성 및 유해성이 알려지면서 소비자의 불안이 가중되고 있다. 합성 방부제의 사용량을 줄이려는 노력이 있으나, 방부제가 첨가되지 않거나 적절한 양에 못 미치는 수준으로 첨가되면 제품의 보관기간이 짧아지고 제품 변질 및 미생물 오염이 문제가 되기 때문에 방부제의 유해성을 인지하고도 방부제를 사용할 수 밖에 없는 현실이다.Preservatives are formulated into cosmetics to suppress the proliferation of microorganisms that contaminate cosmetics from the outside, and to prevent product changes by killing microorganisms over time. Preservatives that are mainly used are synthetic preservatives containing chemical substances, such as paraoxybenzoic acid esters (parabens), imidazolidinyl urea, phenoxyethanol, etc., and diols with two hydroxyl groups. A based compound or surfactant may also be used as a preservative. However, among synthetic preservatives, parabens have problems such as allergic reactions, potential as endocrine disruptors, and induction of resistant bacteria, and diol-based compounds and surfactants have weak antifungal activity and dilute the product, causing problems with formulation stability and skin irritation. It is becoming. As the safety and harmfulness of these synthetic preservatives are known, consumer anxiety is increasing. Efforts have been made to reduce the amount of synthetic preservatives used, but if preservatives are not added or added at a level that is less than the appropriate amount, the shelf life of the product is shortened and product deterioration and microbial contamination become problems. The reality is that you have no choice but to use .
이러한 합성 방부제의 문제점을 극복하기 위해 자연에서 얻은 소재를 이용하거나 이를 포함하는 천연 방부제를 개발하는 연구가 활발히 진행되고 있다. 그 예로, 아니스, 마치현, 병풀, 은행잎, 오매, 쇠뜨기잎 등의 식물에서 추출한 추출물을 합성 방부제와 혼합하여 사용한 시도도 있었다. 그러나 기존 합성 방부제 대비 사용량을 줄이면서 제품의 성능 및 안정성을 모두 확보할 수 있는 방부제에 대한 연구 및 개발이 여전히 요구되고 있다.In order to overcome the problems of these synthetic preservatives, studies using materials obtained from nature or developing natural preservatives containing them are being actively conducted. For example, there has been an attempt to use extracts extracted from plants such as anise, portulaca, centella asiatica, ginkgo biloba, quince leaf, and horsetail leaf by mixing them with synthetic preservatives. However, there is still a need for research and development of preservatives capable of securing both product performance and stability while reducing the amount of use compared to conventional synthetic preservatives.
한편, 천연 항균 물질인 루테린은 넓은 스펙트럼의 항균력을 보이는 물질로 보고되고 있다. 그러나, 아미노산이 존재하는 조건에서 항균력이 떨어지므로 아미노산이 포함된 제품에 적용하는데 어려움이 있다 (염은미 외, 한국식품과학회지 2004. 36(1): 111-115).On the other hand, luterin, a natural antibacterial substance, has been reported as a substance showing a wide spectrum of antimicrobial activity. However, since the antibacterial activity is low in the presence of amino acids, it is difficult to apply to products containing amino acids (Eunmi Yeom et al., Journal of Korean Food Science 2004. 36(1): 111-115).
따라서 합성 방부제, 루테린 등 기존 방부제의 단점을 극복하기 위해서는 많은 연구가 필요한 실정이다.Therefore, many studies are needed to overcome the disadvantages of existing preservatives such as synthetic preservatives and luterin.
[선행기술문헌][Prior art literature]
[특허문헌][Patent Literature]
(특허문헌 1) 대한민국 등록특허 제10-2013565호(Patent Document 1) Republic of Korea Patent Registration No. 10-2013565
(특허문헌 2) 대한민국 등록특허 제10-2136623호(Patent Document 2) Republic of Korea Patent Registration No. 10-2136623
(특허문헌 3) 대한민국 등록특허 제10-1472518호(Patent Document 3) Republic of Korea Patent Registration No. 10-1472518
본 발명은 세균, 진균 등 미생물의 활성을 저해하거나 미생물 사멸을 위한 항균용 조성물, 화장료 조성물 및 화장품 보존용 방부제를 제공하는 것을 목적으로 한다.An object of the present invention is to provide an antibacterial composition for inhibiting the activity of microorganisms such as bacteria and fungi or killing microorganisms, a cosmetic composition, and a preservative for cosmetic preservation.
본 발명의 일 양상은 방부 화합물 및 루테린을 유효성분으로 포함하는 항균용 조성물을 제공한다.One aspect of the present invention provides an antimicrobial composition comprising an antiseptic compound and luterin as active ingredients.
본 발명에서 사용된 “방부 화합물(preservative compound)”은 물질의 화학적 또는 생물학적 변질을 막기 위해 첨가되는 화합물을 의미하며, 보존제 또는 살균제로 사용되는 화합물을 포함하기도 한다. 방부 화합물의 화학 독성을 우려하여 화장품, 식품 및 의약품에는 인체에 독성이 없는 안전한 물질이 사용되어야 하므로, 본 발명에서는 화학적으로 안전하고 무해성이 검증된 방부 화합물이라면 제한 없이 이용 가능하다.The term "preservative compound" used in the present invention refers to a compound added to prevent chemical or biological deterioration of a substance, and may include a compound used as a preservative or disinfectant. In view of the chemical toxicity of preservative compounds, cosmetics, foods, and medicines must use safe substances that are not toxic to the human body, so in the present invention, any preservative compound that is chemically safe and harmless can be used without limitation.
상기 방부 화합물의 일례로는 파라벤(paraben)류, 파라핀(paraffin)류, 알칸디올(alkanediol)류, 페녹시에탄올(phenoxyethanol), 이미다졸리디닐우레아(imidazolidinyl urea), 디아졸리디닐우레아(diazolidinyl urea), 이소프로필알코올(isopropyl alcohol), 클로로펜(chlorophene), 포믹애씨드(formic acid), 피록톤올아민(piroctone olamine), 헥세티딘(hexetidine), 헥사미딘(hexamidine), 이소티아졸리논(isothiazolinone), 하이드록시아세토페논(hydroxyacetophenone), 글리세릴카프릴레이트(glyceryl caprylate), 에틸헥실글리세린(ethylhexylglycerin), 소듐벤조에이트(sodium benzoate) 등이 있으나, 이에 한정되는 것은 아니다.Examples of the preservative compound include parabens, paraffins, alkanediols, phenoxyethanol, imidazolidinyl urea, diazolidinyl urea ), isopropyl alcohol, chlorophene, formic acid, piroctone olamine, hexetidine, hexamidine, isothiazolinone ), hydroxyacetophenone, glyceryl caprylate, ethylhexylglycerin, sodium benzoate, etc., but are not limited thereto.
본 발명의 일 구체예에 따르면, 상기 방부 화합물은 알칸디올, 하이드록시아세토페논, 글리세릴카프릴레이트, 에틸헥실글리세린 및 소듐벤조에이트로 이루어진 군에서 선택된 1종 이상인 것일 수 있다.According to one embodiment of the present invention, the preservative compound may be at least one selected from the group consisting of alkane diol, hydroxyacetophenone, glyceryl caprylate, ethylhexyl glycerin and sodium benzoate.
상기 알칸디올은 탄소끼리 단일 결합으로 사슬을 형성하는 포화 탄화수소 (알칸, Alkane)에 두 개의 수산기(-0H)가 연결된 화합물을 의미하며, 수산기의 위치에 따라 1,2-, 1,3-, 1,4-, 2,3-, 2,4-, 2,5- 등으로 구분된다. 이러한 알칸디올은 주로 화장품, 의약품의 보습 성분으로 사용되었으나, 친수성의 수산기와 소수성의 탄소 사슬을 포함하기 때문에 양친매성을 띠며 미생물의 세포막을 쉽게 침투할 수 있어 우수한 항균력을 나타낸다. 특히 알칸디올의 탄소 사슬이 길어질수록 소수성이 강해지기 때문에 항균력이 증가하지만 체내 흡수율이 강해져 피부 자극이 문제가 되므로, 본 발명에서는 알칸디올의 탄소수가 3 내지 12인 것이 바람직하다. The alkane diol refers to a compound in which two hydroxyl groups (-0H) are connected to a saturated hydrocarbon (alkane) that forms a chain with a single bond between carbons. It is classified as 1,4-, 2,3-, 2,4-, 2,5-, etc. These alkanediols are mainly used as moisturizing ingredients in cosmetics and pharmaceuticals, but since they contain a hydrophilic hydroxyl group and a hydrophobic carbon chain, they are amphiphilic and can easily penetrate cell membranes of microorganisms, thereby exhibiting excellent antibacterial activity. In particular, the longer the carbon chain of the alkanediol, the stronger the hydrophobicity, so the antibacterial activity increases, but the higher the absorption rate in the body, causing skin irritation. In the present invention, the alkanediol preferably has 3 to 12 carbon atoms.
본 발명의 일 구체예에 따르면, 상기 알칸디올은 탄소수 3 내지 12의 알칸디올인 것일 수 있다.According to one embodiment of the present invention, the alkane diol may be an alkane diol having 3 to 12 carbon atoms.
보다 구체적으로, 상기 알칸디올은 프로판디올(propanediol), 부탄디올(butanediol), 펜탄디올(pentanediol), 헥산디올(hexanediol), 옥탄디올(octanediol), 데칸디올(decanediol) 및 도데칸디올(dodecanediol)로 이루어진 군에서 선택된 1종 이상인 것일 수 있다.More specifically, the alkanediol includes propanediol, butanediol, pentanediol, hexanediol, octanediol, decanediol and dodecanediol. It may be one or more selected from the group consisting of.
본 발명의 일 구체예에 따르면, 상기 알칸디올은 프로판디올, 부탄디올, 펜탄디올, 헥산디올 및 옥탄디올로 이루어진 군에 선택된 1종 이상인 것일 수 있다.According to one embodiment of the present invention, the alkanediol may be at least one selected from the group consisting of propanediol, butanediol, pentanediol, hexanediol, and octanediol.
특히 알칸디올의 수산기가 모여있을수록 친수성이 향상되므로, 항균력 강화를 위해서는 1,2-알칸디올, 1,3-알칸디올 또는 2,3-알칸디올이 바람직하다. 예를 들면, 1,2-프로판디올, 1,3-프로판디올, 1,2-부탄디올, 1,3-부탄디올, 2,3-부탄디올, 1,2-펜탄디올, 1,3-펜탄디올, 2,3-펜탄디올, 1,2-헥산디올, 1,3-헥산디올, 2,3-헥산디올, 1,2-옥탄디올, 1,3-옥탄디올, 2,3-옥탄디올 등일 수 있으나, 이제 제한되지 않는다.In particular, since hydrophilicity improves as hydroxyl groups of alkanediol are concentrated, 1,2-alkanediol, 1,3-alkanediol, or 2,3-alkanediol is preferable to enhance antibacterial activity. For example, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 2,3-butanediol, 1,2-pentanediol, 1,3-pentanediol, 2,3-pentanediol, 1,2-hexanediol, 1,3-hexanediol, 2,3-hexanediol, 1,2-octanediol, 1,3-octanediol, 2,3-octanediol, etc. However, it is no longer limited.
상기 하이드록시아세토페논은 식물 유래 성분으로 화장품의 천연 산화방지제로 사용되며, 파라벤류에 비해 방부력은 약하지만 피부에 더 친화적이며 파라벤을 비롯한 다른 방부제와 함께 사용할 경우 방부 기능이 증대되는 물질이다. 이러한 하이드록시아세토페논은 하이드록시기(-OH)의 위치에 따라 2-, 3- 및 4-하이드록시아세토페논으로 구분되나, 방부 기능에 있어서는 차이가 없다.The hydroxyacetophenone is a plant-derived ingredient used as a natural antioxidant in cosmetics, and has a weaker preservative power than parabens, but is more skin-friendly and increases the preservative function when used with other preservatives including parabens. These hydroxyacetophenones are classified into 2-, 3- and 4-hydroxyacetophenones according to the position of the hydroxy group (-OH), but there is no difference in preservative function.
상기 글리세릴카프릴레이트는 식물 유래 성분으로 일종의 계면활성제 역할을 하여 주로 화장품에서 유화제로 사용되며, 항세균 및 항진균 효과가 우수하여 방부대체원료로 사용 가능하다.The glyceryl caprylate is a plant-derived ingredient that serves as a kind of surfactant and is mainly used as an emulsifier in cosmetics, and has excellent antibacterial and antifungal effects, so it can be used as a substitute for preservatives.
상기 에틸헥실글리세린은 습윤 특성이 있어 화장품의 보습 효과를 위해 주로 사용되지만 통상의 방부제인 페녹시에탄올, 이소티아졸리논, 파라벤 등의 항균력을 증가시키는 역할도 하여 이러한 방부제의 사용량을 줄이는데 사용된다. 또한, 인체에서 냄새를 유발하는 혐기성 박테리아의 성장을 억제하는 항균 활성도 있다.The ethylhexylglycerin has a wetting property and is mainly used for the moisturizing effect of cosmetics, but also serves to increase the antibacterial power of common preservatives such as phenoxyethanol, isothiazolinone, and paraben, and is used to reduce the amount of such preservatives. It also has antibacterial activity that inhibits the growth of odor-causing anaerobic bacteria in the human body.
상기 소듐벤조에이트는 세균, 효모, 곰팡이 등 다양한 미생물의 생육을 억제하는 효과가 있는 화합물로, 값이 저렴하고 항균 효과가 우수할 뿐만 아니라 독성도 낮아 주로 식품 보존제로 사용되며, 화장품에서는 파라벤을 대체하는 합성 보존제 중 하나이다.The sodium benzoate is a compound that is effective in inhibiting the growth of various microorganisms such as bacteria, yeast, and fungi. It is inexpensive, has excellent antibacterial effect, and is low in toxicity, and is mainly used as a food preservative. In cosmetics, it replaces parabens. It is one of the synthetic preservatives.
본 발명에서 사용된 “루테린(reuterin)”은 락토바실러스 루테리(Lactobacillus reuteri)가 글리세롤로부터 생산하는 천연 항미생물 물질인 3-하이드록시프로피온알데하이드(3-hydroxypropionaldehyde)를 말한다. 상기 루테린은 병원성 세균뿐만 아니라 효모, 곰팡이 등에 대한 항균력을 보유하고 있어 항균 스펙트럼이 매우 넓은 특성을 가지고 있다 (Doleyres et al., Appl Microbiol Biotechnol 2005, 68: 467-474). As used in the present invention, “reuterin” refers to 3-hydroxypropionaldehyde, a natural antimicrobial substance produced by Lactobacillus reuteri from glycerol. The luterin has antibacterial activity against not only pathogenic bacteria but also yeast and mold, and thus has a very broad antibacterial spectrum (Doleyres et al., Appl Microbiol Biotechnol 2005, 68: 467-474).
본 발명의 일 구체예에 따르면, 상기 루테린은 락토바실러스 루테리 또는 이의 배양액으로부터 분리된 것일 수 있다.According to one embodiment of the present invention, the luterin may be isolated from Lactobacillus reuteri or a culture medium thereof.
본 발명에서 사용된 "배양액"은 락토바실러스 루테리의 생존, 발육 또는 증식에 필요한 영양물질을 의미하며, 상기 락토바실러스 루테리가 생산하여 외부로 분비하는 효소, 대사산물 등도 포함할 수 있다.The "culture medium" used in the present invention refers to nutrients necessary for the survival, development, or proliferation of Lactobacillus reuteri, and may also include enzymes and metabolites produced by the Lactobacillus reuteri and secreted to the outside.
이러한 방부 화합물 및 루테린을 포함하는 조성물은 항균 활성을 나타낼 수 있다.A composition comprising such an antiseptic compound and luterin may exhibit antibacterial activity.
본 발명에서 사용된 "항균(antimicrobial)"은 어떤 농도에서 세균, 진균 등의 미생물 성장 또는 생존을 감소, 방지, 억제 또는 제거하는 능력을 의미하며, "항균용 조성물"은 이러한 항균력을 나타내는 물질을 포함하는 조성물을 의미한다."Antimicrobial" as used in the present invention means the ability to reduce, prevent, inhibit or eliminate the growth or survival of microorganisms such as bacteria and fungi at a certain concentration, and "antimicrobial composition" refers to substances exhibiting such antibacterial activity. means a composition comprising
본 발명의 일 구체예에 따르면, 상기 항균용 조성물은 세균 및 진균에 대해 항균 활성을 가지는 것일 수 있다.According to one embodiment of the present invention, the antimicrobial composition may have antibacterial activity against bacteria and fungi.
본 발명의 일 구체예에 따르면, 상기 항균용 조성물은 에세리키아(Escherichia) 속, 스테필로코커스(Staphylococcus) 속, 슈도모나스(Pseudomonas) 속, 칸디다(Candida) 속 및 아스퍼질러스(Aspergillus) 속으로 이루어진 군에서 선택된 1종 이상의 세균에 대해 항균 활성을 가지는 것일 수 있다.According to one embodiment of the present invention, the antibacterial composition is Escherichia (Escherichia ) genus, Staphylococcus ( Staphylococcus ) genus, Pseudomonas ( Pseudomonas ) genus, Candida ( Candida ) and Aspergillus ( Aspergillus ) genus It may have antibacterial activity against one or more bacteria selected from the group consisting of.
상기 항균용 조성물은 방부 화합물 및 루테린을 포함함으로써 기존에 항균력을 내기 위해 사용되는 방부 화합물 또는 루테린의 사용량에 비해 적은 양으로도 충분한 항균 활성을 나타내며 제품의 제형 안정성을 유지하고 보관기간을 연장할 수 있다.The antibacterial composition contains a preservative compound and luterin, thereby exhibiting sufficient antibacterial activity even in a small amount compared to the amount of preservative compound or luterin used for antibacterial activity in the past, maintaining formulation stability of the product and extending shelf life. can do.
본 발명의 일 구체예에 따르면, 상기 항균용 조성물은 전체 중량을 기준으로 방부 화합물 0.01 내지 50 중량%를 포함하는 것일 수 있다.According to one embodiment of the present invention, the antimicrobial composition may be one containing 0.01 to 50% by weight of an antiseptic compound based on the total weight.
보다 구체적으로, 상기 방부 화합물의 사용량은 항균용 조성물의 전체 중량을 기준으로 0.01 내지 50 중량%, 0.01 내지 10 중량%, 0.01 내지 5 중량%, 0.01 내지 1 중량%, 0.05 내지 50 중량%, 0.05 내지 10 중량%, 0.05 내지 5 중량%, 0.05 내지 1 중량%, 0.1 내지 50 중량%, 0.1 내지 10 중량%, 0.1 내지 5 중량%, 0.1 내지 1 중량%, 0.5 내지 50 중량%, 0.5 내지 10 중량%, 0.5 내지 5 중량%, 0.5 내지 1 중량%, 1 내지 50 중량%, 1 내지 10 중량%, 1 내지 5 중량%, 5 내지 50 중량%, 또는 10 내지 50 중량%일 수 있다.More specifically, the amount of the preservative compound is 0.01 to 50% by weight, 0.01 to 10% by weight, 0.01 to 5% by weight, 0.01 to 1% by weight, 0.05 to 50% by weight, 0.05 to 50% by weight based on the total weight of the antimicrobial composition. to 10 wt%, 0.05 to 5 wt%, 0.05 to 1 wt%, 0.1 to 50 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 1 wt%, 0.5 to 50 wt%, 0.5 to 10 0.5 to 5 wt%, 0.5 to 1 wt%, 1 to 50 wt%, 1 to 10 wt%, 1 to 5 wt%, 5 to 50 wt%, or 10 to 50 wt%.
상기 방부 화합물의 사용량이 0.01 중량% 미만인 경우에는 세균 및 진균에 대해 항균력이 나타나지 않고 항균력 향상을 위해 많은 양의 루테린 사용이 불가피하며, 상기 방부 화합물의 사용량이 50 중량%를 초과한 경우에는 제품이 묽어져 제형 안정성에 문제가 생기며 피부 자극이 크게 증가할 수 있다.When the amount of the preservative compound is less than 0.01% by weight, antibacterial activity against bacteria and fungi is not shown, and a large amount of luterin is unavoidable to improve antibacterial activity, and when the amount of the preservative compound exceeds 50% by weight, the product This thinning may cause a problem with formulation stability and greatly increase skin irritation.
또한, 본 발명의 일 구체예에 따르면, 상기 항균용 조성물은 0.05 내지 50 mM의 루테린을 포함하는 것일 수 있다.Further, according to one embodiment of the present invention, the antimicrobial composition may contain 0.05 to 50 mM of luterin.
상기 루테린의 농도는 항균용 조성물 중 0.05 내지 50 mM, 0.05 내지 10 mM, 0.05 내지 5 mM, 0.1 내지 50 mM, 0.1 내지 10 mM, 0.1 내지 5 mM, 0.5 내지 50 mM, 0.5 내지 10 mM, 0.5 내지 5 mM, 1 내지 50 mM, 1 내지 10 mM, 또는 1 내지 5 mM일 수 있다.The concentration of luterin in the antimicrobial composition is 0.05 to 50 mM, 0.05 to 10 mM, 0.05 to 5 mM, 0.1 to 50 mM, 0.1 to 10 mM, 0.1 to 5 mM, 0.5 to 50 mM, 0.5 to 10 mM, 0.5 to 5 mM, 1 to 50 mM, 1 to 10 mM, or 1 to 5 mM.
상기 루테린의 농도가 0.05 mM 미만인 경우에는 항균 활성을 나타내지 않거나 일부 미생물에서만 제한적인 항균력을 보일 수 있으며, 상기 루테린의 농도가 50 mM을 초과한 경우에는 제형 안정성에 부정적인 영향을 줄 수 있다.If the concentration of luterin is less than 0.05 mM, it may not exhibit antibacterial activity or may show limited antibacterial activity only in some microorganisms, and if the concentration of luterin exceeds 50 mM, formulation stability may be adversely affected.
본 발명의 일 실시예에 따르면, 루테린은 단독 사용으로도 세균 (E. Coli, P. aeruginosa 및 S. aureus)과 진균 (C. albicans 및 A. niger)에 대해 항균력을 나타내지만, 방부 화합물, 즉 알칸디올 (1,3-프로판디올, 2,3-부탄디올, 1,2-펜탄디올, 1,2-헥산디올 또는 1,2-옥탄디올), 하이드록시아세토페논, 글리세릴카프릴레이트, 에틸헥실글리세린 또는 소듐벤조에이트와의 혼용을 통해 루테린 단독 사용에 비해 적은 양만으로도 동일하거나 보다 우수한 항균력을 나타냄을 확인하였다.According to one embodiment of the present invention, luterin exhibits antibacterial activity against bacteria ( E. Coli , P. aeruginosa and S. aureus ) and fungi ( C. albicans and A. niger ) even when used alone, but is a preservative compound. , namely alkanediol (1,3-propanediol, 2,3-butanediol, 1,2-pentanediol, 1,2-hexanediol or 1,2-octanediol), hydroxyacetophenone, glyceryl caprylate, It was confirmed that the mixed use with ethylhexylglycerin or sodium benzoate showed the same or better antibacterial activity with only a small amount compared to the use of luterin alone.
이러한 항균용 조성물은 액상, 유상, 크림상, 페이스트상, 고체상 등 어떠한 제형으로도 응용될 수 있으며, 전신, 피부, 구강, 모발 등 신체에 적용되는 제품에 이용될 수 있다. This antibacterial composition can be applied in any formulation such as liquid, oil, cream, paste, solid, etc., and can be used for products applied to the body, such as the body, skin, oral cavity, and hair.
본 발명에 따른 항균용 조성물은 사용 목적 또는 양상에 따라 다양한 분야에서 활용될 수 있으며, 일례로 화장료 조성물 또는 이의 첨가제로 구체화될 수 있다. 상기 첨가제는 제품의 미생물에 의한 변질, 부패, 변색 및 화학 변화를 방지하기 위한 첨가물로서 방부제, 보존제, 살균제 등일 수 있으며, 전체 화장료 조성물 중량을 기준으로 0.01 내지 50 중량%, 0.5 내지 25 중량%, 0.1 내지 10 중량%, 또는 0.5 내지 5 중량%가 포함될 수 있다.The antibacterial composition according to the present invention may be utilized in various fields depending on the purpose or aspect of use, and may be embodied as, for example, a cosmetic composition or an additive thereof. The additive is an additive for preventing deterioration, decay, discoloration, and chemical change of the product by microorganisms, and may be a preservative, a preservative, a bactericide, etc., based on the total weight of the cosmetic composition, 0.01 to 50% by weight, 0.5 to 25% by weight, 0.1 to 10% by weight, or 0.5 to 5% by weight may be included.
본 발명에 따른 항균용 조성물은 화장료 조성물로 구현될 수 있다.Antibacterial composition according to the present invention can be implemented as a cosmetic composition.
본 발명의 일 구체예에 따르면, 상기 화장료 조성물은 항균 성분으로 방부 화합물 및 루테린을 유효성분으로 포함하는 것일 수 있다. According to one embodiment of the present invention, the cosmetic composition may contain an antibacterial compound and luterin as active ingredients.
여기서 방부 화합물 및 루테린에 관한 설명은 상술한 바와 동일하므로, 중복 기재를 피하기 위해 생략한다.Since the description of the preservative compound and luterin is the same as described above, it is omitted to avoid redundant description.
상기 화장료 조성물은 방부 화합물 및 루테린 외에도 화장료 조성물에 통상적으로 사용되는 성분들을 더 포함할 수 있으며, 예를 들면 항산화제, 안정화제, 용해화제, 비타민, 안료, 향료 등을 더 포함할 수 있다.In addition to the preservative compound and luterin, the cosmetic composition may further include ingredients commonly used in cosmetic compositions, for example, antioxidants, stabilizers, solubilizers, vitamins, pigments, fragrances, and the like.
상기 화장료 조성물은 통상 당업계에서 사용되는 제형으로 제한 없이 제조될 수 있으며, 예를 들면, 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 마사지크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 영양에센스, 팩, 비누, 샴푸, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션, 바디클렌저, 유액, 립스틱, 메이크업 베이스, 파운데이션, 프레스파우더, 루스파우더, 아이섀도 등의 제형으로 제조될 수 있다.The cosmetic composition may be prepared without limitation in formulations commonly used in the art, for example, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrient lotion, massage cream, nutrient cream , Moisture Cream, Hand Cream, Essence, Nutrition Essence, Pack, Soap, Shampoo, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body Lotion, Body Cleanser, Emulsion, Lipstick, Makeup Base, Foundation, Press Powder, Loose Powder, Eye Shadow It can be prepared in formulations such as
본 발명의 일 구체예에 따르면, 상기 화장료 조성물은 전체 중량을 기준으로 방부 화합물 0.01 내지 50 중량%를 포함하는 것일 수 있다.According to one embodiment of the present invention, the cosmetic composition may include 0.01 to 50% by weight of an antiseptic compound based on the total weight.
보다 구체적으로, 상기 방부 화합물의 사용량은 화장료 조성물의 전체 중량을 기준으로 0.01 내지 50 중량%, 0.01 내지 10 중량%, 0.01 내지 5 중량%, 0.01 내지 1 중량%, 0.05 내지 50 중량%, 0.05 내지 10 중량%, 0.05 내지 5 중량%, 0.05 내지 1 중량%, 0.1 내지 50 중량%, 0.1 내지 10 중량%, 0.1 내지 5 중량%, 0.1 내지 1 중량%, 0.5 내지 50 중량%, 0.5 내지 10 중량%, 0.5 내지 5 중량%, 0.5 내지 1 중량%, 1 내지 50 중량%, 1 내지 10 중량%, 1 내지 5 중량%, 5 내지 50 중량%, 또는 10 내지 50 중량%일 수 있다. More specifically, the amount of the preservative compound is 0.01 to 50% by weight, 0.01 to 10% by weight, 0.01 to 5% by weight, 0.01 to 1% by weight, 0.05 to 50% by weight, 0.05 to 50% by weight based on the total weight of the cosmetic composition. 10 wt%, 0.05 to 5 wt%, 0.05 to 1 wt%, 0.1 to 50 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 1 wt%, 0.5 to 50 wt%, 0.5 to 10 wt% %, 0.5 to 5%, 0.5 to 1%, 1 to 50%, 1 to 10%, 1 to 5%, 5 to 50%, or 10 to 50%.
또한, 본 발명의 일 구체예에 따르면, 상기 화장료 조성물은 0.05 내지 50 mM의 루테린을 포함하는 것일 수 있다.In addition, according to one embodiment of the present invention, the cosmetic composition may contain 0.05 to 50 mM of luterin.
상기 루테린의 농도는 화장료 조성물 중 0.05 내지 50 mM, 0.05 내지 10 mM, 0.05 내지 5 mM, 0.1 내지 50 mM, 0.1 내지 10 mM, 0.1 내지 5 mM, 0.5 내지 50 mM, 0.5 내지 10 mM, 0.5 내지 5 mM, 1 내지 50 mM, 1 내지 10 mM, 또는 1 내지 5 mM일 수 있다.The concentration of luterin in the cosmetic composition is 0.05 to 50 mM, 0.05 to 10 mM, 0.05 to 5 mM, 0.1 to 50 mM, 0.1 to 10 mM, 0.1 to 5 mM, 0.5 to 50 mM, 0.5 to 10 mM, 0.5 to 5 mM, 1 to 50 mM, 1 to 10 mM, or 1 to 5 mM.
또한, 본 발명에 따른 항균용 조성물은 화장품 보존용 방부제로 구현될 수 있다.In addition, the antibacterial composition according to the present invention can be implemented as a preservative for preserving cosmetics.
본 발명의 일 구체예에 따르면, 상기 화장품 보존용 방부제는 방부 화합물 및 루테린을 유효성분으로 포함하는 화장품 보존용 방부제일 수 있다.According to one embodiment of the present invention, the preservative for preserving cosmetics may be a preservative for preserving cosmetics containing a preservative compound and luterin as active ingredients.
여기서 방부 화합물 및 루테린에 관한 설명은 상술한 바와 동일하므로, 중복 기재를 피하기 위해 생략한다.Since the description of the preservative compound and luterin is the same as described above, it is omitted to avoid redundant description.
상기 화장품 보존용 방부제는 부패를 방지하기 위해 화장품 제조에 사용되는 첨가제로서 특히 생물학적 변질을 예방하는 역할을 한다.The preservative for preserving cosmetics is an additive used in manufacturing cosmetics to prevent spoilage, and particularly serves to prevent biological deterioration.
본 발명의 일 구체예에 따르면, 상기 화장품 보존용 방부제는 전체 중량을 기준으로 방부 화합물 0.01 내지 50 중량%를 포함하는 것일 수 있다.According to one embodiment of the present invention, the preservative for preserving cosmetics may include 0.01 to 50% by weight of a preservative compound based on the total weight.
보다 구체적으로, 상기 방부 화합물의 사용량은 화장품 보존용 방부제의 전체 중량을 기준으로 0.01 내지 50 중량%, 0.01 내지 10 중량%, 0.01 내지 5 중량%, 0.01 내지 1 중량%, 0.05 내지 50 중량%, 0.05 내지 10 중량%, 0.05 내지 5 중량%, 0.05 내지 1 중량%, 0.1 내지 50 중량%, 0.1 내지 10 중량%, 0.1 내지 5 중량%, 0.1 내지 1 중량%, 0.5 내지 50 중량%, 0.5 내지 10 중량%, 0.5 내지 5 중량%, 0.5 내지 1 중량%, 1 내지 50 중량%, 1 내지 10 중량%, 1 내지 5 중량%, 5 내지 50 중량%, 또는 10 내지 50 중량%일 수 있다. More specifically, the amount of the preservative compound is 0.01 to 50% by weight, 0.01 to 10% by weight, 0.01 to 5% by weight, 0.01 to 1% by weight, 0.05 to 50% by weight, based on the total weight of the preservative for cosmetic preservation. 0.05 to 10% by weight, 0.05 to 5% by weight, 0.05 to 1% by weight, 0.1 to 50% by weight, 0.1 to 10% by weight, 0.1 to 5% by weight, 0.1 to 1% by weight, 0.5 to 50% by weight, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 1 wt%, 1 to 50 wt%, 1 to 10 wt%, 1 to 5 wt%, 5 to 50 wt%, or 10 to 50 wt%.
또한, 본 발명의 일 구체예에 따르면, 상기 화장품 보존용 방부제는 0.05 내지 50 mM의 루테린을 포함하는 것일 수 있다.Further, according to one embodiment of the present invention, the preservative for preserving cosmetics may contain 0.05 to 50 mM of luterin.
상기 루테린의 농도는 화장품 보존용 방부제 중 0.05 내지 50 mM, 0.05 내지 10 mM, 0.05 내지 5 mM, 0.1 내지 50 mM, 0.1 내지 10 mM, 0.1 내지 5 mM, 0.5 내지 50 mM, 0.5 내지 10 mM, 0.5 내지 5 mM, 1 내지 50 mM, 1 내지 10 mM, 또는 1 내지 5 mM일 수 있다.The concentration of luterin is 0.05 to 50 mM, 0.05 to 10 mM, 0.05 to 5 mM, 0.1 to 50 mM, 0.1 to 10 mM, 0.1 to 5 mM, 0.5 to 50 mM, 0.5 to 10 mM in the preservative for cosmetic preservation. , 0.5 to 5 mM, 1 to 50 mM, 1 to 10 mM, or 1 to 5 mM.
상기 화장품 보존용 방부제는 제품의 종류 및 사용 목적에 따라 통상 사용되는 성분을 더 포함할 수 있으며, 예를 들면, 초산, 초산나트륨계, 소르빈산계, 안식향산계, 프로피온산계 등을 더 포함할 수 있다.The preservative for preserving cosmetics may further include components commonly used depending on the type and purpose of use of the product, and may further include, for example, acetic acid, sodium acetate-based, sorbic acid-based, benzoic acid-based, propionic acid-based, etc. .
본 발명에 따른 항균용 조성물은 방부 화합물 및 루테린을 포함함으로써 방부 화합물의 사용량을 최소화하여 제형 안정성을 개선시킬 수 있고 방부 화합물 또는 루테린 단독 사용에 비해 사용량이 감소되어도 제형 내 항균력을 확보할 수 있어 방부 화합물 또는 루테린의 단점을 보완한 화장료 조성물, 화장품 보존용 방부제 등으로 활용될 수 있다.The antibacterial composition according to the present invention can improve formulation stability by minimizing the amount of preservative compound and luterin by including a preservative compound and luterin, and can secure antimicrobial activity in the formulation even if the amount used is reduced compared to the use of a preservative compound or luterin alone. It can be used as a preservative compound or a cosmetic composition that compensates for the disadvantages of luterin, a preservative for cosmetic preservation, and the like.
도 1은 본 발명의 일 실시예에 따른 항균용 조성물을 포함한 화장료 조성물의 점도 변화를 나타낸 그래프이다.1 is a graph showing the change in viscosity of a cosmetic composition including an antibacterial composition according to an embodiment of the present invention.
이하, 본 발명을 보다 상세하게 설명한다. 그러나, 이러한 설명은 본 발명의 이해를 돕기 위하여 예시적으로 제시된 것일 뿐, 본 발명의 범위가 이러한 예시적인 설명에 의하여 제한되는 것은 아니다.Hereinafter, the present invention will be described in more detail. However, these descriptions are merely presented as examples to aid understanding of the present invention, and the scope of the present invention is not limited by these exemplary descriptions.
준비예 1. 방부 화합물 및 루테린 준비Preparation Example 1. Preparation of preservative compound and luterin
1-1. 방부 화합물1-1. preservative compound
방부 화합물로서 1,3-프로판디올(1,3-PD), 2,3-부탄디올(2,3-BD), 1,2-펜탄디올(1,2-PD), 1,2-헥산디올(1,2-HD) 및 1,2-옥탄디올(1,2-OD)의 알칸디올, 4-하이드록시아세토페논(4-HA), 글리세릴카프릴레이트(GC), 에틸헥실글리세린(EHG) 및 소듐벤조에이트(SB)를 사용하였다.1,3-propanediol (1,3-PD), 2,3-butanediol (2,3-BD), 1,2-pentanediol (1,2-PD), 1,2-hexanediol as preservative compounds Alkanediols of (1,2-HD) and 1,2-octanediol (1,2-OD), 4-hydroxyacetophenone (4-HA), glycerylcaprylate (GC), ethylhexylglycerin (EHG) ) and sodium benzoate (SB) were used.
1-2. 루테린1-2. luterin
루테린은 미생물 배양을 통해 수득하여 사용하였다.Reuterin was obtained and used through microbial culture.
간략하게 설명하면, 5L 배양기에서 락토바실러스 루테리 BR201 균주를 이용하여 MRS 배지 (10 g/L의 프로테오스 펩톤 NO.3, 10 g/L의 쇠고기 추출물, 5 g/L의 효모 추출물, 20 g/L의 덱스트로스, 1 g/L의 폴리솔베이트 80, 2 g/L의 암모늄 시트레이트, 5 g/L의 소듐 아세테이트, 0.1 g/L의 마그네슘 설페이트, 0.05 g/L의 망가니즈 설페이트 및 2 g/L의 디포타슘 설페이트 함유)에서 배양 후 배양액을 13,000 rpm으로 5분간 원심분리한 후 셀을 회수하여 50 mM 소듐 포스페이트 버퍼 (pH 7.5)에 2회 세척하였다. 세척된 셀은 200 mM 글리세롤 용액에 재현탁하여 30℃ 배양기에서 정치반응하며 1시간 간격으로 시료를 채취하였다. 농도가 100 mM인 루테린을 수득하여 이후 실시예에서 사용하였다.Briefly, MRS medium (10 g/L Proteose Peptone NO.3, 10 g/L beef extract, 5 g/L yeast extract, 20 g /L dextrose, 1 g/L polysorbate 80, 2 g/L ammonium citrate, 5 g/L sodium acetate, 0.1 g/L magnesium sulfate, 0.05 g/L manganese sulfate, and After culturing in 2 g/L of dipotassium sulfate), the culture medium was centrifuged at 13,000 rpm for 5 minutes, and the cells were collected and washed twice in 50 mM sodium phosphate buffer (pH 7.5). The washed cells were resuspended in a 200 mM glycerol solution, allowed to stand in an incubator at 30° C., and samples were taken at intervals of 1 hour. Reuterin at a concentration of 100 mM was obtained and used in subsequent examples.
실시예 1. 항균용 조성물의 항균 평가Example 1. Antibacterial evaluation of antibacterial composition
알칸디올 및 루테린을 포함하는 항균용 조성물에 대한 항균 평가를 실시하였다.Antibacterial evaluation was performed on the antibacterial composition containing alkanediol and luterin.
1-1. MIC 평가 1-1. MIC evaluation
항균용 조성물의 항균력 테스트에서는 미국약전(USP)에서 지정한 세균 3종 (Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027, Staphylococcus aureus ATCC 6538)과 진균 2종 (Candida albicans ATCC 10231, Aspergillus niger ATCC 16404)을 이용하여 MIC(minimal inhibitory concentration) 방법을 실시하였다. 상기 세균은 TSB 배지에, 진균은 SDB 배지에 2회 계대 배양 후 실험에 사용하였다.In the antimicrobial activity test of the antibacterial composition, three types of bacteria ( Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027, Staphylococcus aureus ATCC 6538) and two types of fungi ( Candida albicans ATCC 10231, Aspergillus niger ATCC 16404) designated by the United States Pharmacopoeia (USP) were used. MIC (minimal inhibitory concentration) method was performed. The bacteria were subcultured twice in TSB medium and the fungi in SDB medium, and then used in experiments.
먼저 각 배지 (세균 - TSB 배지, 진균 - SDB 배지)에 항균용 조성물로서 루테린 단독 또는 루테린과 알칸디올을 1 : 1의 중량비로 혼합하여 0.5 내지 4 중량%가 되도록 첨가하였고, 이때 배지 내 최종 루테린 농도는 0.5 내지 4 mM이었다. 이후 세균을 107 cfu/ml가 되도록 접종하여 37℃에서 1일간 배양하거나, 또는 진균을 105 cfu/ml가 되도록 접종하여 30℃에서 2일간 배양하여 MIC 값을 확인하였다. 그 결과는 하기 표 1에 나타내었다.First, as an antimicrobial composition for each medium (bacteria - TSB medium, fungus - SDB medium), luterin alone or luterin and alkanediol were mixed at a weight ratio of 1: 1 and added to 0.5 to 4% by weight. At this time, in the medium The final luterin concentration was 0.5 to 4 mM. Thereafter, bacteria were inoculated to a concentration of 10 7 cfu/ml and cultured at 37°C for 1 day, or fungi were inoculated to a concentration of 10 5 cfu/ml and cultured at 30°C for 2 days to confirm the MIC value. The results are shown in Table 1 below.
MIC (wt%)MIC (wt%) | |||||
E. ColiE. Coli | S. AureusS. Aureus | P. aeruginosaP. aeruginosa | C. albicansC. albicans | A. nigerA. niger | |
루테린luterin | 44 | 22 | 22 | 44 | 22 |
루테린+1,2-HDReuterin+1,2-HD | 22 | 22 | 22 | 22 | 22 |
상기 표 1과 같이, 방부제로 루테린 단독 사용한 경우에는 E. coil와 C. albicans에 대해 루테린 4 중량% (루테린 4 mM)에서 항균력이 나타났으나, 루테린과 1,2-HD을 혼합 사용한 경우에는 루테린 1 중량% (루테린 1 mM)에서 항균력을 확인하여 루테린 단독 사용 대비 상승되는 항균력을 보임을 확인하였다.
As shown in Table 1, when luterin alone was used as a preservative, antibacterial activity was shown at 4 wt% luterin (luterin 4 mM) against E. coil and C. albicans , but luterin and 1,2-HD In the case of mixed use, the antibacterial activity was confirmed in 1 wt% of luterin (1 mM of luterin), and it was confirmed that the antibacterial activity was increased compared to the use of luterin alone.
1-2. MBC 평가1-2. MBC evaluation
항균용 조성물은 0.85% NaCl 완충액에 알칸디올 (1,3-프로판디올, 2,3-부탄디올, 1,2-펜단디올, 1,2-헥산디올 또는 1,2-옥탄디올) 0.1 내지 30 중량% 및/또는 루테린 0.1 내지 3 중량% (0.1 내지 3 mM)를 첨가하여 제조하였다. 항균용 조성물 10 mL에 C. albicans 또는 A. niger를 105 cfu/mL 접종하여 30℃ 배양기에서 72시간 진탕(shaking) 배양하였다. 이후 배양액 100 μL를 SDA 고체배지에 도말하고 30℃ 배양기에서 48 시간 배양하여 균 생장 여부를 관찰하였다. C. albicans 및 A. niger에 대한 MBC(minimum bactericidal concentration) 평가 결과는 각각 하기 표 2 및 3에 나타내었다.The antibacterial composition contains 0.1 to 30 wt. weight of alkanediol (1,3-propanediol, 2,3-butanediol, 1,2-pentanediol, 1,2-hexanediol or 1,2-octanediol) in 0.85% NaCl buffer. % and/or 0.1 to 3 wt% (0.1 to 3 mM) of lutein. 10 5 cfu/mL of C. albicans or A. niger was inoculated in 10 mL of the antibacterial composition and cultured with shaking for 72 hours in a 30°C incubator. Thereafter, 100 μL of the culture medium was spread on SDA solid medium and cultured for 48 hours in a 30° C. incubator to observe bacterial growth. The MBC (minimum bactericidal concentration) evaluation results for C. albicans and A. niger are shown in Tables 2 and 3, respectively.
C. albicansC. albicans | 루테린 (mM)Reuterin (mM) | ||||||||
00 | 0.10.1 | 0.50.5 | 1.01.0 | 1.51.5 | 2.02.0 | 3.03.0 | |||
알칸디올 미첨가Alkanediol not added | XX | XX | XX |
X | OO | OO | 00 | ||
1,3-PD (wt%)1,3-PD (wt%) |
1 One | XX | XX | XX | OO | OO | OO | OO | |
22 | XX | XX | OO | OO | OO | OO | OO | ||
33 | XX | OO | OO | OO | OO | OO | OO | ||
2,3-BD (wt%)2,3-BD (wt%) |
1010 | XX | XX | XX | OO | OO | OO | OO | |
1515 | OO | OO | OO | OO | OO | OO | OO | ||
2020 | OO | OO | OO | OO | OO | OO | OO | ||
2525 | OO | OO | OO | OO | OO | OO | OO | ||
3030 | OO | OO | OO | OO | OO | OO | OO | ||
1,2-PD (wt%)1,2-PD (wt%) |
33 | XX | XX | XX | OO | OO | OO | OO | |
55 | XX | OO | OO | OO | OO | OO | OO | ||
88 | OO | OO | OO | OO | OO | OO | OO | ||
1,2-HD (wt%)1,2-HD (wt%) |
1.01.0 | XX | XX | XX | OO | OO | OO | OO | |
2.02.0 | OO | OO | OO | OO | OO | OO | OO | ||
2.52.5 | OO | OO | OO | OO | OO | OO | OO | ||
3.03.0 | OO | OO | OO | OO | OO | OO | OO | ||
1,2-OD (wt%)1,2-OD (wt%) |
0.10.1 | XX | XX | XX | OO | OO | OO | OO | |
0.30.3 | XX | XX | XX | OO | OO | OO | OO | ||
0.50.5 | XX | OO | OO | OO | OO | OO | OO | ||
X: 항균력 없음 (균 생장함), O: 항균력 있음 (균 생장 없음)X: No antibacterial activity (bacterial growth), O: Antibacterial activity (no bacterial growth) |
A. nigerA. niger | 루테린 (mM)Reuterin (mM) | ||||||||
00 | 0.10.1 | 0.50.5 | 1.01.0 | 1.51.5 | 2.02.0 | 3.03.0 | |||
알칸디올 미첨가Alkanediol not added | XX | XX | XX |
X | OO | OO | 00 | ||
1,3-PD (wt%)1,3-PD (wt%) |
1 One | XX | XX | XX | XX | OO | OO | OO | |
22 | XX | XX | XX | OO | OO | OO | OO | ||
33 | XX | OO | OO | OO | OO | OO | OO | ||
2,3-BD (wt%)2,3-BD (wt%) |
1010 | XX | XX | XX | OO | OO | OO | OO | |
1515 | XX | XX | XX | OO | OO | OO | OO | ||
2020 | XX | XX | OO | OO | OO | OO | OO | ||
2525 | XX | XX | OO | OO | OO | OO | OO | ||
3030 | XX | OO | OO | OO | OO | OO | OO | ||
1,2-PD (wt%)1,2-PD (wt%) |
33 | XX | XX | XX | OO | OO | OO | OO | |
55 | XX | XX | OO | OO | OO | OO | OO | ||
88 | XX | OO | OO | OO | OO | OO | OO | ||
1,2-HD (wt%)1,2-HD (wt%) |
1.01.0 | XX | XX | XX | OO | OO | OO | OO | |
2.02.0 | XX | XX | XX | OO | OO | OO | OO | ||
2.52.5 | XX | XX | OO | OO | OO | OO | OO | ||
3.03.0 | XX | OO | OO | OO | OO | OO | OO | ||
1,2-OD (wt%)1,2-OD (wt%) |
0.10.1 | XX | XX | XX | OO | OO | OO | OO | |
0.30.3 | XX | XX | XX | OO | OO | OO | OO | ||
0.50.5 | XX | XX | OO | OO | OO | OO | OO | ||
X: 항균력 없음 (균 생장함), O: 항균력 있음 (균 생장 없음)X: No antibacterial activity (bacterial growth), O: Antibacterial activity (no bacterial growth) |
상기 표 2 및 3을 참고하면, C. albicans에 대해, 1,3-프로판디올 1 ~ 3 중량%, 2,3-부탄디올 10 중량%, 1,2-펜탄디올 3 ~ 5 중량%, 1,2-헥산디올 1 중량% 또는 1,2-옥탄디올 0.1 ~ 0.5 중량%는 항균 활성이 없는 것으로 나타났으나, 0.1 ~ 3 mM의 루테린을 더 포함할 경우 항진균 활성이 나타나는 것을 확인하였다. 또한, A. niger에 대해, 1,3-프로판디올 1 ~ 3 중량%, 2,3-부탄디올 10 ~ 30 중량%, 1,2-펜탄디올 3 ~ 8 중량%, 1,2-헥산디올 1 ~ 3 중량% 또는 1,2-옥탄디올 0.1 ~ 0.5 중량%는 항균 활성이 나타나지 않으나, 0.1 ~ 3 mM의 루테린을 더 포함할 경우 항세균 활성이 나타난 것을 확인하였다. 따라서 알칸디올 및 루테린을 포함하는 조성물은 두 물질의 조합을 통해 단독 물질 대비 상승되는 항균력을 가지는 것을 알 수 있었다. Referring to Tables 2 and 3, for C. albicans , 1 to 3% by weight of 1,3-propanediol, 10% by weight of 2,3-butanediol, 3 to 5% by weight of 1,2-pentanediol, 1, 1% by weight of 2-hexanediol or 0.1 to 0.5% by weight of 1,2-octanediol was found to have no antibacterial activity, but antifungal activity was confirmed when 0.1 to 3 mM of luterin was further included. In addition, for A. niger , 1 to 3% by weight of 1,3-propanediol, 10 to 30% by weight of 2,3-butanediol, 3 to 8% by weight of 1,2-pentanediol, 1,2-hexanediol ~ 3% by weight or 0.1 ~ 0.5% by weight of 1,2-octanediol did not show antibacterial activity, but it was confirmed that antibacterial activity was exhibited when 0.1 ~ 3 mM of luterin was further included. Therefore, it was found that the composition containing alkanediol and luterin had an increased antibacterial activity compared to the single material through the combination of the two materials.
실시예 2. 화장료 조성물의 제형 안정성 평가Example 2. Evaluation of Formulation Stability of Cosmetic Composition
2-1. 화장료 조성물의 제조2-1. Preparation of cosmetic composition
알칸디올 단독, 또는 알칸디올 및 루테린을 포함하는 화장료 조성물을 제조하여 제형 안정성을 확인하였다. 알칸디올로서 1,2-HD를 사용하였다.Formulation stability was confirmed by preparing a cosmetic composition containing an alkanediol alone or an alkanediol and luterin. 1,2-HD was used as the alkanediol.
화장료 조성물의 원료 및 함량은 하기 표 4와 같으며, 로션의 제형으로 제조하였다.The raw materials and contents of the cosmetic composition are shown in Table 4 below, and were prepared in a lotion formulation.
원료명raw material name | 화장료 조성물 1Cosmetic Composition 1 | 화장료 조성물 2Cosmetic Composition 2 |
Carbopol 981Carbopol 981 | 0.2 wt%0.2wt% | 0.2 wt%0.2wt% |
GlycerinGlycerin | 5.0 wt%5.0wt% | 5.0 wt%5.0wt% |
Cetyl alcoholCetyl alcohol | 0.5 wt%0.5wt% | 0.5 wt%0.5wt% |
Stearyl alcoholStearyl alcohol | 0.5 wt%0.5wt% | 0.5 wt%0.5wt% |
MCTMCTs | 2.0 wt%2.0wt% | 2.0 wt%2.0wt% |
LP 70LP 70 | 3.0 wt%3.0wt% | 3.0 wt%3.0wt% |
Olivem 1000Olivem 1000 | 1.5 wt%1.5wt% | 1.5 wt%1.5wt% |
TriethanolamineTriethanolamine | 0.2 wt%0.2wt% | 0.2 wt%0.2wt% |
1,2-HD1,2-HD | 3.0 wt%3.0wt% |
1.0 wt%1.0 |
ReuterinReuterin | 00 | 1.0 wt% (1 mM)1.0 wt % (1 mM) |
Distilled waterDistilled water | To 100 wt%To 100wt% | To 100 wt%To 100wt% |
2-2. 제형 안정성 평가2-2. Formulation stability evaluation
화장료 조성물 1 및 2를 상온에서 60일간 보관한 후 제형의 점도 변화를 관찰하였다. 각각의 화장료 조성물을 투명한 용기에 담아 25℃에서 64번 스핀들(spindle)이 장착된 점도계 (LV pro VISCOMETER, BROOKFIELD)를 50 rpm으로 작동하여 점도 평가 (단위: cps)를 진행하였다. After storing the cosmetic compositions 1 and 2 at room temperature for 60 days, the viscosity change of the formulation was observed. Viscosity evaluation (unit: cps) was conducted by putting each cosmetic composition in a transparent container and operating a viscometer (LV pro VISCOMETER, BROOKFIELD) equipped with a No. 64 spindle at 25 ° C. at 50 rpm.
그 결과, 도 1에 나타낸 바와 같이, 1,2-HD을 단독으로 포함하는 화장료 조성물 1은 점도 하강 현상이 발생하였으나, 1,2-HD 및 루테린을 포함하는 화장료 조성물 2는 점도 변화가 없는 것을 확인하였다.As a result, as shown in FIG. 1, cosmetic composition 1 containing 1,2-HD alone showed a decrease in viscosity, but cosmetic composition 2 containing 1,2-HD and luterin showed no change in viscosity. confirmed that
실시예 3. 항균용 조성물의 항균 평가Example 3. Antibacterial evaluation of antibacterial composition
하이드록시아세토페논, 글리세릴카프릴레이트, 에틸헥실글리세린 또는 소듐벤조에이트 및 루테린을 포함하는 항균용 조성물에 대한 항균 평가를 실시하였다.An antimicrobial composition containing hydroxyacetophenone, glyceryl caprylate, ethylhexyl glycerin or sodium benzoate, and luterin was subjected to antibacterial evaluation.
3-1. 항진균 평가 3-1. Antifungal evaluation
진균에 대한 항균력 테스트에서는 미국약전(USP)에서 지정한 진균 Candida albicans ATCC 10231 및 Aspergillus niger ATCC 16404를 이용하였다. C. albicans는 SDB 배지에 2회 계대 배양하여 사용하였고, A. niger는 SDA 배지에 도말하여 수득한 포자를 실험에 사용하였다.In the antibacterial activity test against fungi, fungi Candida albicans ATCC 10231 and Aspergillus niger ATCC 16404 designated by the United States Pharmacopoeia (USP) were used. C. albicans was subcultured twice in SDB medium, and A. niger spores obtained by plating on SDA medium were used in the experiment.
0.8% NaCl 수용액에 항균용 조성물로서 루테린 단독 또는 루테린과 방부 화합물을 각각의 농도로 첨가하였고, 이때 최종 루테린 농도는 0.5 내지 1.5 mM이었다. 이후 진균을 105 cfu/ml가 되도록 접종하여 30℃에서 3일간 보관 뒤, SDA 배지에 100 uL를 도말하였다. 도말한 시료는 30℃에서 3일간 배양하여 균락(colony) 형성 유무를 확인하였다. 그 결과는 하기 표 5에 나타내었다.As an antibacterial composition, luterin alone or luterin and an antiseptic compound were added at respective concentrations to a 0.8% NaCl aqueous solution, and the final concentration of luterin was 0.5 to 1.5 mM. Thereafter, the fungus was inoculated to 10 5 cfu/ml, stored at 30° C. for 3 days, and then 100 uL was smeared on SDA medium. The smeared samples were incubated at 30° C. for 3 days to confirm whether or not colonies were formed. The results are shown in Table 5 below.
방부 화합물preservative compound | 루테린 (mM)Reuterin (mM) | C. albicansC. albicans | A. nigerA. niger |
미첨가not added | 00 | OO | OO |
0.50.5 | OO | OO | |
1One | OO | OO | |
1.51.5 | XX | XX | |
4-HA 0.1 wt%4-HA 0.1wt% |
00 | OO | OO |
0.50.5 | XX | XX | |
1One | XX | XX | |
1.51.5 | XX | XX | |
4-HA 0.2 wt%4-HA 0.2wt% |
00 | OO | OO |
0.50.5 | XX | XX | |
1One | XX | XX | |
1.51.5 | XX | XX | |
GC 0.1 wt%GC 0.1wt% |
00 | OO | OO |
0.50.5 | XX | OO | |
1One | XX | XX | |
1.51.5 | XX | XX | |
GC 0.2 wt%GC 0.2wt% |
00 | OO | OO |
0.50.5 | XX | OO | |
1One | XX | XX | |
1.51.5 | XX | XX | |
EHG 0.05 wt%EHG 0.05wt% |
00 | OO | OO |
0.50.5 | XX | OO | |
1One | XX | XX | |
1.51.5 | XX | XX | |
EHG 0.1 wt%EHG 0.1wt% |
00 | XX | OO |
0.50.5 | XX | XX | |
1One | XX | XX | |
1.51.5 | XX | XX | |
SB 0.3 wt%SB 0.3wt% |
00 | OO | OO |
0.50.5 | XX | OO | |
1One | XX | XX | |
1.51.5 | XX | XX | |
SB 0.4 wt%SB 0.4wt% |
00 | OO | OO |
0.50.5 | XX | OO | |
1One | XX | XX | |
1.51.5 | XX | XX | |
X: 항균력 없음 (균 생장함), O: 항균력 있음 (균 생장 없음)X: No antibacterial activity (bacterial growth), O: Antibacterial activity (no bacterial growth) |
상기 표 5를 참조하면, C. albicans에 대해서는 에틸헥실글리세린 0.05 중량%를 제외하고 하이드록시아세토페논 0.1 ~ 0.2 중량%, 글리세릴카프릴레이트 0.1 ~ 0.2 중량%, 에틸헥실글리세린 0.05 중량% 또는 소듐벤조에이트 0.3 ~ 0.4 중량%를 단독 사용 시 항진균 활성이 없었으나, 농도에 관계없이 루테린을 더 포함할 경우 항진균 활성이 나타나는 것을 확인하였다.Referring to Table 5, for C. albicans , 0.1 to 0.2% by weight of hydroxyacetophenone, 0.1 to 0.2% by weight of glyceryl caprylate, 0.05% by weight of ethylhexylglycerin or sodium benzoate, except for 0.05% by weight of ethylhexylglycerin. When 0.3 to 0.4% by weight of ate was used alone, there was no antifungal activity, but it was confirmed that antifungal activity was exhibited when luterin was further included regardless of the concentration.
또한 A. niger에 대해서는 하이드록시아세토페논 0.1 ~ 0.2 중량%, 글리세릴카프릴레이트 0.1 ~ 0.2 중량%, 에틸헥실글리세린 0.05 ~ 0.1 중량% 또는 소듐벤조에이트 0.3 ~ 0.4 중량%를 단독 사용 시 항진균 활성이 없었으나, 루테린 농도가 증가함에 따라 항진균 활성이 나타나는 것을 확인하였다.
In addition, for A. niger , antifungal activity was observed when 0.1 to 0.2% by weight of hydroxyacetophenone, 0.1 to 0.2% by weight of glyceryl caprylate, 0.05 to 0.1% by weight of ethylhexylglycerin, or 0.3 to 0.4% by weight of sodium benzoate was used alone. However, it was confirmed that antifungal activity appeared as the concentration of luterin increased.
3-2. 항세균 평가3-2. Antibacterial evaluation
세균에 대한 항균력 테스트에서는 미국약전(USP)에서 지정한 세균 Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027 및 Staphylococcus aureus ATCC 6538를 이용하였다. 세균은 TSB 배지에 2회 계대 배양한 후 실험에 사용하였다.In the antibacterial test against bacteria, Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027, and Staphylococcus aureus ATCC 6538 designated by the United States Pharmacopoeia (USP) were used. Bacteria were subcultured twice in TSB medium and used in experiments.
0.8% NaCl 수용액에 항균용 조성물로서 루테린 단독 또는 루테린과 방부 화합물을 각각의 농도로 첨가하였고, 이때 최종 루테린 농도는 0.5 내지 1.5 mM이었다. 이후 세균을 107 cfu/ml가 되도록 접종하여 37℃에서 3일간 보관 뒤, TSA 배지에 100 uL를 도말하였다. 도말한 시료는 37℃에서 배양하여 균락(colony) 형성 유무를 확인하였다. 그 결과는 하기 표 6에 나타내었다.As an antibacterial composition, luterin alone or luterin and an antiseptic compound were added at respective concentrations to a 0.8% NaCl aqueous solution, and the final concentration of luterin was 0.5 to 1.5 mM. Thereafter, the bacteria were inoculated to a concentration of 10 7 cfu/ml, stored at 37° C. for 3 days, and then 100 uL was smeared on a TSA medium. The smeared sample was incubated at 37 ° C. to confirm the presence or absence of colony formation. The results are shown in Table 6 below.
방부 화합물preservative compound | 루테린 (mM)Reuterin (mM) | E. coliE. coli | P. aeruginosaP. aeruginosa | S. aureusS. aureus |
미첨가not added | 00 | OO | OO | OO |
0.50.5 | OO | OO | OO | |
1One | OO | OO | OO | |
1.51.5 | XX | XX | XX | |
4-HA 0.1 wt%4-HA 0.1wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
4-HA 0.2 wt%4-HA 0.2wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
GC 0.1 wt%GC 0.1wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
GC 0.2 wt%GC 0.2wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
EHG 0.05 wt%EHG 0.05wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
EHG 0.1 wt%EHG 0.1wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
SB 0.3 wt%SB 0.3wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
SB 0.4 wt%SB 0.4wt% |
00 | OO | OO | OO |
0.50.5 | XX | XX | XX | |
1One | XX | XX | XX | |
1.51.5 | XX | XX | XX | |
X: 항균력 없음 (균 생장함), O: 항균력 있음 (균 생장 없음)X: No antibacterial activity (bacterial growth), O: Antibacterial activity (no bacterial growth) |
상기 표 6을 참조하면, 각 방부 화합물을 단독 사용한 경우에는 3종의 세균에 대해 항균 활성이 없었으나, 루테린을 첨가할 경우 항세균 활성이 나타나며, 루테린을 단독 사용한 경우에 비해 저농도의 루테린 첨가로 우수한 항세균 활성을 발휘하는 것을 확인하였다.Referring to Table 6, when each preservative compound was used alone, there was no antibacterial activity against three types of bacteria, but when luterin was added, antibacterial activity was shown, and a lower concentration of lutein than when luterin was used alone It was confirmed that the addition of terin exerted excellent antibacterial activity.
실시예 4. 화장료 조성물의 제형 안정성 및 항균력 유지 평가Example 4. Formulation stability and antibacterial activity maintenance evaluation of cosmetic composition
2-1. 화장료 조성물의 제조2-1. Preparation of cosmetic composition
화장료 조성물에서의 방부 화합물 (하이드록시아세토페논, 글리세릴카프릴레이트, 에틸헥실글리세린 또는 소듐벤조에이트) 및/또는 루테린의 항균력을 확인하기 위해 하기 표 7 및 8과 같이 로션 및 시트마스크 제형의 화장료 조성물을 제조하였다.Cosmetics of lotion and sheet mask formulations as shown in Tables 7 and 8 below to confirm the antimicrobial activity of preservative compounds (hydroxyacetophenone, glyceryl caprylate, ethylhexylglycerin or sodium benzoate) and / or luterin in cosmetic compositions A composition was prepared.
로션 제형lotion formulation | |||||
원료명raw material name | 화장료 조성물 3Cosmetic Composition 3 | 화장료 조성물 4Cosmetic Composition 4 | 화장료 조성물 5Cosmetic Composition 5 | 화장료 조성물 6Cosmetic Composition 6 |
화장료 조성물 7 |
BUTYLENE GLYCOLBUTYLENE GLYCOL | 5.005.00 | 5.005.00 | 5.005.00 | 5.005.00 | 5.005.00 |
GLYCERINGLYCERIN | 4.004.00 | 4.004.00 | 4.004.00 | 4.004.00 | 4.004.00 |
CETYL ETHYLHEXANOATECETYL ETHYLHEXANOATE | 2.502.50 | 2.502.50 | 2.502.50 | 2.502.50 | 2.502.50 |
GLYCERYL STEARATEGLYCERYL STEARATE | 1.781.78 | 1.781.78 | 1.781.78 | 1.781.78 | 1.781.78 |
CETEARYL ALCOHOLCETEARYL ALCOHOL | 1.501.50 | 1.501.50 | 1.501.50 | 1.501.50 | 1.501.50 |
CAPRYLIC/CAPRIC TRIGLYCERIDECAPRYLIC/CAPRIC TRIGLYCERIDE | 1.501.50 | 1.501.50 | 1.501.50 | 1.501.50 | 1.501.50 |
OLEA EUROPAEA (OLIVE) FRUIT OILOLEA EUROPAEA (OLIVE) FRUIT OIL | 1.001.00 | 1.001.00 | 1.001.00 | 1.001.00 | 1.001.00 |
PEG-100 STEARATEPEG-100 STEARATE | 0.720.72 | 0.720.72 | 0.720.72 | 0.720.72 | 0.720.72 |
BUTYROSPERMUM PARKII(SHEA) BUTTERBUTYROSPERMUM PARKII(SHEA) BUTTER | 0.500.50 | 0.500.50 | 0.500.50 | 0.500.50 | 0.500.50 |
TROMETHAMINETROMETHAMINE | 0.400.40 | 0.400.40 | 0.400.40 | 0.400.40 | 0.400.40 |
CARBOMERCARBOMER | 0.400.40 | 0.400.40 | 0.400.40 | 0.400.40 | 0.400.40 |
XANTHAN GUMXANTHAN GUM | 0.050.05 | 0.050.05 | 0.050.05 | 0.050.05 | 0.050.05 |
DISODIUM EDTADISODIUM EDTA | 0.020.02 | 0.020.02 | 0.020.02 | 0.020.02 | 0.020.02 |
ALLANTOINALLANTOIN | 0.010.01 | 0.010.01 | 0.010.01 | 0.010.01 | 0.010.01 |
HYDROXYACETOPHENONEHYDROXYACETOPHENONE | -- | 0.100.10 | -- | -- | -- |
ETHYLHEXYLGLYCERINETHYLHEXYLGLYCERIN | -- | -- | 0.050.05 | -- | -- |
GLYCERYL CAPYLATEGLYCERYL CAPYLATE | -- | -- | -- | 0.20.2 | -- |
SODIUM BENZOATESODIUM BENZOATE | -- | -- | -- | -- | 0.40.4 |
REUTERINREUTERIN | 1 mM1 mM | 1 mM1 mM | 1 mM1 mM | 1 mM1 mM | 1 mM1 mM |
WaterWater | To 100 wt%To 100wt% | To 100 wt%To 100wt% | To 100 wt%To 100wt% | To 100 wt%To 100wt% | To 100 wt%To 100wt% |
시트마스크 제형sheet mask formulation | |||||
원료명raw material name | 화장료 조성물 8cosmetic composition 8 | 화장료 조성물 9Cosmetic Composition 9 | 화장료 조성물 10cosmetic composition 10 | 화장료 조성물 11cosmetic composition 11 | 화장료 조성물 12cosmetic composition 12 |
BUTYLENE GLYCOLBUTYLENE GLYCOL | 5.055.05 | 5.055.05 | 5.055.05 | 5.055.05 | 5.055.05 |
GLYCERINGLYCERIN | 2.002.00 | 2.002.00 | 2.002.00 | 2.002.00 | 2.002.00 |
DIETHOXYETHYL SUCCINATEDIETHOXYETHYL SUCCINATE | 2.002.00 | 2.002.00 | 2.002.00 | 2.002.00 | 2.002.00 |
PANTHENOLPANTHENOL | 0.980.98 | 0.980.98 | 0.980.98 | 0.980.98 | 0.980.98 |
TROMETHAMINETROMETHAMINE | 0.100.10 | 0.100.10 | 0.100.10 | 0.100.10 | 0.100.10 |
CARBOMERCARBOMER | 0.100.10 | 0.100.10 | 0.100.10 | 0.100.10 | 0.100.10 |
BETAINEBETAINE | 0.100.10 | 0.100.10 | 0.100.10 | 0.100.10 | 0.100.10 |
SODIUM HYALURONATESODIUM HYALURONATE | 0.010.01 | 0.010.01 | 0.010.01 | 0.010.01 | 0.010.01 |
HYDROXYACETOPHENONEHYDROXYACETOPHENONE | -- | 0.100.10 | -- | -- | -- |
ETHYLHEXYLGLYCERINETHYLHEXYLGLYCERIN | -- | -- | 0.050.05 | -- | -- |
GLYCERYL CAPYLATEGLYCERYL CAPYLATE | -- | -- | -- | 0.20.2 | -- |
SODIUM BENZOATESODIUM BENZOATE | -- | -- | -- | -- | 0.40.4 |
REUTERINREUTERIN | 1 mM1 mM | 1 mM1 mM | 1 mM1 mM | 1 mM1 mM | 1 mM1 mM |
WATERWATER | To 100 wt%To 100wt% | To 100 wt%To 100wt% | To 100 wt%To 100wt% | To 100 wt%To 100wt% | To 100 wt%To 100wt% |
4-2. 화장료 제형에서의 항균력 평가4-2. Evaluation of antibacterial activity in cosmetic formulations
화장료 조성물에서의 항균력 평가를 위해 상기 제형들을 이용하여 테스트를 진행하였다. 항균력 테스트에서는 미국약전(USP)에서 지정한 세균 및 진균 (Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027, Staphylococcus aureus ATCC 6538, Candida albicans ATCC 10231 및 Aspergillus niger ATCC 16404)을 이용하였다. 세균과 C. albicans는 각각 TSB와 SDB 배지에 2회 계대 배양한 후 실험에 사용하였고, A. niger는 SDA 배지에 도말하여 수득한 포자를 실험에 사용하였다.To evaluate the antibacterial activity in the cosmetic composition, a test was conducted using the above formulations. In the antibacterial test, bacteria and fungi designated by the United States Pharmacopoeia (USP) ( Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027, Staphylococcus aureus ATCC 6538, Candida albicans ATCC 10231 and Aspergillus niger ATCC 16404) were used. Bacteria and C. albicans were subcultured twice in TSB and SDB medium, respectively, and used in the experiment, and A. niger spores obtained by plating on SDA medium were used in the experiment.
각각의 화장료 조성물에 세균의 경우 107 cfu/ml가, 진균의 경우 105 cfu/ml가 되도록 접종한 후 각각 37℃와 30℃에서 3일간 보관하였다. 100 uL의 시료를 900 uL의 Letheen 배지에 혼합한 뒤 세균의 경우 TSA에, 진균의 경우 SDA에 각각 도말하였다. 도말한 시료는 각각 37℃와 30℃에서 3일간 배양하여 균락(colony) 형성 유무를 확인하였다. 그 결과는 하기 표 9에 나타내었다.Each cosmetic composition was inoculated to 10 7 cfu/ml for bacteria and 10 5 cfu/ml for fungi, and then stored at 37°C and 30°C for 3 days, respectively. After mixing 100 uL of the sample with 900 uL of Letheen medium, it was smeared on TSA for bacteria and SDA for fungi, respectively. The smeared samples were incubated at 37 ° C and 30 ° C for 3 days, respectively, to confirm the presence or absence of colony formation. The results are shown in Table 9 below.
E. coliE. coli | P. aeruginosaP. aeruginosa | S. aureusS. aureus | C. albicansC. albicans | A. nigerA. niger | |
화장료 조성물 3Cosmetic Composition 3 | OO | OO | OO | OO | OO |
화장료 조성물 4Cosmetic Composition 4 | XX | XX | XX | XX | XX |
화장료 조성물 5Cosmetic Composition 5 | XX | XX | XX | XX | XX |
화장료 조성물 6Cosmetic Composition 6 | XX | XX | XX | XX | XX |
화장료 조성물 7Cosmetic Composition 7 | XX | XX | XX | XX | XX |
화장료 조성물 8cosmetic composition 8 | OO | OO | OO | OO | OO |
화장료 조성물 9Cosmetic Composition 9 | XX | XX | XX | XX | XX |
화장료 조성물 10cosmetic composition 10 | XX | XX | XX | XX | XX |
화장료 조성물 11cosmetic composition 11 | XX | XX | XX | XX | XX |
화장료 조성물 12cosmetic composition 12 | XX | XX | XX | XX | XX |
X: 항균력 없음 (균 생장함), O: 항균력 있음 (균 생장 없음)X: No antibacterial activity (bacterial growth), O: Antibacterial activity (no bacterial growth) |
상기 표 9를 참조하면, 제형에 관계없이 방부 화합물 및 루테린을 포함하는 화장료 조성물은 제형 변화 없이 세균 및 진균에 대해 항균 활성을 가지는 것을 확인하였다.Referring to Table 9, regardless of the formulation, it was confirmed that the cosmetic composition containing the preservative compound and luterin had antibacterial activity against bacteria and fungi without changing the formulation.
4-3. 화장료 제형에서의 항균력 유지 평가4-3. Evaluation of maintenance of antibacterial activity in cosmetic formulations
화장료 제형에서의 항균력이 유지되는지 확인하기 위해 '4-2. 화장료 제형에서의 항균력 평가'에서 사용한 세균 또는 진균 접종 시료 (화장료 조성물 4 ~ 7 및 9 ~ 12)를 이용하여 각각의 균주를 누적 접종하여 항균력이 유지되는지를 확인하였다. 세균의 경우 3종, 즉 E. coli, P. aeruginosa 및 S. aureus을 혼합하여 107 CFU/ml이 되도록 접종하였고, 진균의 경우 C. albicans 및 A. niger를 각각 105 CFU/ml이 되도록 접종하였다. 각 균주의 접종은 7일 마다 동일한 시료에 접종을 하였으며, 접종이 완료된 시료는 매 접종 3일차에 100 uL의 시료를 900 uL의 Letheen 배지에 혼합한 뒤 TSA와 SDA에 각각 도말하여 균락 형성 유무를 확인하였다. 그 결과는 하기 표 10에 나타내었다.In order to check whether the antibacterial activity in the cosmetic formulation is maintained, '4-2. It was confirmed whether the antibacterial activity was maintained by cumulatively inoculating each strain using the bacterial or fungal inoculated samples (cosmetic compositions 4 to 7 and 9 to 12) used in 'Evaluation of antibacterial activity in cosmetic formulations'. In the case of bacteria, three species, namely E. coli , P. aeruginosa and S. aureus were mixed and inoculated to 10 7 CFU/ml, and in the case of fungi, C. albicans and A. niger were mixed to 10 5 CFU/ml, respectively. Inoculated. Inoculation of each strain was inoculated into the same sample every 7 days, and for the sample after inoculation, 100 uL of the sample was mixed with 900 uL of Letheen medium on the 3rd day of each inoculation, and then smeared on TSA and SDA, respectively, to check for colon formation. Confirmed. The results are shown in Table 10 below.
화장료 조성물 4Cosmetic Composition 4 | 화장료 조성물 5Cosmetic Composition 5 | 화장료 조성물 6Cosmetic Composition 6 |
화장료 조성물 7 |
화장료 조성물 9Cosmetic Composition 9 | 화장료 조성물 10cosmetic composition 10 | 화장료 조성물 11cosmetic composition 11 | 화장료 조성물 12cosmetic composition 12 | ||
1차 접종1st inoculation | 세균 3종3 types of bacteria | XX | XX | XX | XX | XX | XX | XX | XX |
C. albicansC. albicans | XX | XX | XX | XX | XX | XX | XX | XX | |
A. nigerA. niger | XX | XX | XX | XX | XX | XX | XX | XX | |
2차 접종2nd dose | 세균3 종3 types of bacteria | XX | XX | XX | XX | XX | XX | XX | XX |
C. albicansC. albicans | XX | XX | XX | XX | XX | XX | XX | XX | |
A. nigerA. niger | XX | XX | XX | XX | XX | XX | XX | XX | |
3차 접종3rd dose | 세균 3종3 types of bacteria | XX | XX | XX | XX | XX | XX | XX | XX |
C. albicansC. albicans | XX | XX | XX | XX | XX | XX | XX | XX | |
A. nigerA. niger | XX | XX | XX | XX | XX | XX | XX | XX | |
4차 접종4th inoculation | 세균 3종3 types of bacteria | XX | XX | XX | XX | XX | XX | XX | XX |
C. albicansC. albicans | XX | XX | XX | XX | XX | XX | XX | XX | |
A. nigerA. niger | XX | XX | XX | XX | XX | XX | XX | XX | |
X: 항균력 없음 (균 생장함), O: 항균력 있음 (균 생장 없음)X: No antibacterial activity (bacterial growth), O: Antibacterial activity (no bacterial growth) |
상기 표 10을 참조하면, 제형에 관계없이 방부 화합물 및 루테린을 포함하는 화장료 조성물은 제형 변화 없이 세균 및 진균에 대해 항균 활성이 안정적으로 지속되는 것을 확인하였다.Referring to Table 10, regardless of the formulation, it was confirmed that the cosmetic composition containing the preservative compound and luterin stably maintained antibacterial activity against bacteria and fungi without changing the formulation.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far, the present invention has been looked at with respect to its preferred embodiments. Those of ordinary skill in the art to which the present invention pertains will understand that the present invention can be implemented in a modified form without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments should be considered from an illustrative rather than a limiting point of view. The scope of the present invention is shown in the claims rather than the foregoing description, and all differences within the equivalent scope will be construed as being included in the present invention.
Claims (8)
- 방부 화합물 및 루테린을 유효성분으로 포함하는 항균용 조성물.An antibacterial composition comprising an antiseptic compound and luterin as active ingredients.
- 청구항 1에 있어서,The method of claim 1,상기 방부 화합물은 알칸디올, 하이드록시아세토페논, 글리세릴카프릴레이트, 에틸헥실글리세린 및 소듐벤조에이트로 이루어진 군에서 선택된 1종 이상인 것인 항균용 조성물.The antiseptic compound is an antimicrobial composition of at least one selected from the group consisting of alkane diol, hydroxyacetophenone, glyceryl caprylate, ethylhexyl glycerin and sodium benzoate.
- 청구항 2에 있어서,The method of claim 2,상기 알칸디올은 탄소수 3 내지 12의 알칸디올인 것인 항균용 조성물.The alkane diol is an antimicrobial composition of the alkane diol having 3 to 12 carbon atoms.
- 청구항 1에 있어서,The method of claim 1,상기 항균용 조성물은 세균 및 진균에 대해 항균 활성을 가지는 것인 항균용 조성물.The antimicrobial composition is an antimicrobial composition having antibacterial activity against bacteria and fungi.
- 청구항 1에 있어서,The method of claim 1,상기 항균용 조성물은 전체 중량을 기준으로 방부 화합물 0.01 내지 50 중량%를 포함하는 것인 항균용 조성물.The antimicrobial composition is an antimicrobial composition comprising 0.01 to 50% by weight of the preservative compound based on the total weight.
- 청구항 1에 있어서,The method of claim 1,상기 항균용 조성물은 0.05 내지 50 mM의 루테린을 포함하는 것인 항균용 조성물.The antimicrobial composition is an antimicrobial composition comprising 0.05 to 50 mM of luterin.
- 방부 화합물 및 루테린을 유효성분으로 포함하는 화장료 조성물.A cosmetic composition comprising an antiseptic compound and luterin as active ingredients.
- 방부 화합물 및 루테린을 유효성분으로 포함하는 화장품 보존용 방부제.A preservative for preserving cosmetics containing a preservative compound and luterin as active ingredients.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2021-0143977 | 2021-10-26 | ||
KR1020210143977A KR102394120B1 (en) | 2021-10-26 | 2021-10-26 | Antimicrobial composition comprising alkanediol and reuterin and use thereof |
KR10-2022-0034592 | 2022-03-21 | ||
KR1020220034592A KR20230137014A (en) | 2022-03-21 | 2022-03-21 | Antimicrobial composition comprising preservative compound and reuterin and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023075165A1 true WO2023075165A1 (en) | 2023-05-04 |
Family
ID=86158350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/014266 WO2023075165A1 (en) | 2021-10-26 | 2022-09-23 | Antimicrobial composition comprising antiseptic compound and reuterin, and use thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023075165A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08256746A (en) * | 1995-03-20 | 1996-10-08 | Asama Kasei Kk | Preservative for food |
JPH08289769A (en) * | 1995-04-20 | 1996-11-05 | Asama Kasei Kk | Preservative for food |
US20070264401A1 (en) * | 2006-05-12 | 2007-11-15 | Taormina Peter J | Beverage preservatives |
US20160271189A1 (en) * | 2015-03-18 | 2016-09-22 | Whole Biome, Inc. | Methods and compositions relating to microbial treatment and diagnosis of skin disorders |
US20190343894A1 (en) * | 2017-01-05 | 2019-11-14 | Georgia State University Research Foundation, Inc. | Antimicrobial compositions and methods of using same |
KR102394120B1 (en) * | 2021-10-26 | 2022-05-04 | 코오롱인더스트리(주) | Antimicrobial composition comprising alkanediol and reuterin and use thereof |
-
2022
- 2022-09-23 WO PCT/KR2022/014266 patent/WO2023075165A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08256746A (en) * | 1995-03-20 | 1996-10-08 | Asama Kasei Kk | Preservative for food |
JPH08289769A (en) * | 1995-04-20 | 1996-11-05 | Asama Kasei Kk | Preservative for food |
US20070264401A1 (en) * | 2006-05-12 | 2007-11-15 | Taormina Peter J | Beverage preservatives |
US20160271189A1 (en) * | 2015-03-18 | 2016-09-22 | Whole Biome, Inc. | Methods and compositions relating to microbial treatment and diagnosis of skin disorders |
US20190343894A1 (en) * | 2017-01-05 | 2019-11-14 | Georgia State University Research Foundation, Inc. | Antimicrobial compositions and methods of using same |
KR102394120B1 (en) * | 2021-10-26 | 2022-05-04 | 코오롱인더스트리(주) | Antimicrobial composition comprising alkanediol and reuterin and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111031794B (en) | Antimicrobial mixture containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and organic acid compound, and cosmetic composition containing the same | |
US11207252B2 (en) | Synergistic preservative blends | |
KR102093827B1 (en) | Cosmetic compositions containing poly(butyl cyanoacrylate) | |
KR102262466B1 (en) | Preservative system comprising lactobacillus acidophilus ferment and antispetic | |
WO2022092903A1 (en) | Preservative for agent to be externally applied to skin, comprising alkanediol and caprylyl glyceryl ether or ethylhexylglycerin, and cosmetic composition comprising same | |
KR20150107376A (en) | Antibacterials composition comprising Sedum extract composition and food additives and preparation method thereof | |
KR102394120B1 (en) | Antimicrobial composition comprising alkanediol and reuterin and use thereof | |
KR102394531B1 (en) | Antiseptic containing caprylic/capric glycerides and composition for skin external application containing thereof | |
WO2023229309A1 (en) | Lactobacillus paracasei uos1 strain and antibacterial composition including same | |
WO2023075165A1 (en) | Antimicrobial composition comprising antiseptic compound and reuterin, and use thereof | |
KR102154252B1 (en) | Composition for Antimicrobial and Antifungal Comprising Baicalein and Wogonin as Active Ingredient | |
JP7445910B2 (en) | Oral compositions, oral care products, and foods containing oral resident bacteria regulators | |
KR102260163B1 (en) | Antimicrobial Cosmetic Composition | |
WO2023080483A1 (en) | Preservative for external skin application comprising magnolol, honokiol, or combination thereof, and cosmetic composition comprising same | |
KR102009604B1 (en) | Antimicrobial composition comprising lonicera japonica extract and magnolia obovata extract | |
KR20180031119A (en) | Natural antimicrobial composition and cosmetic composition containing the same | |
KR20230137014A (en) | Antimicrobial composition comprising preservative compound and reuterin and use thereof | |
KR102227751B1 (en) | Natural antiseptic substitute comprising extraction mixture of Schisandra chinensis, Thymus quinquecostatus and Elsholtzia splendens as effective component and uses thereof | |
KR101683631B1 (en) | A composition for inhibiting microbial activity comprising niaouli leaf extracts | |
WO2024117424A1 (en) | Cosmetic composition for maintaining balance of skin microbiome comprising saccharomyces cerevisiae extract and 1,3-propanediol | |
KR20210007577A (en) | Antimicrobial composition comprising Morus alba bark extract, Brussels sprout extract, Soapberry extract and Angelica keiskei extract | |
KR20240083000A (en) | Cosmetic composition for maintaining microbiome balance in the skin comprising extract of brewer's yeast and 1,3-propanediol | |
WO2024049114A1 (en) | Topical skin composition containing 1,3-propanediol as active ingredient for maintaining microbiome balance in skin | |
KR102363112B1 (en) | Composition for inhibiting microbial growth comprising 1,2-hexanediol and glyceryl caprylate | |
KR102566760B1 (en) | Preservative composition comprising natural extracts and cosmetic composition comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22887369 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |